CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: cyproconazole
Accession: CHEBI:81758
browse the term
Definition: A diastereoisomeric mixture composed of the enantiomeric pair (2R,3S)- and (2S,3R)-cyproconazole in ratio 1:1 with the enantiomeric pair (2R,3R)- and (2S,3S)-cyproconazole. A broad spectrum fungicide, it is used on cereals and other field crops used to control Septoria, rust, powdery mildew and other diseases.
Synonyms: exact_synonym: rac-2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol
related_synonym: alpha-(4-chlorophenyl)-alpha-(1-cyclopropylethyl)-1N-1,2,4-triazole-1-ethanol
xref: CAS:94361-06-5; KEGG:C18456
xref_mesh: MESH:C093628
xref: PMID:23708404; PMID:24691702; PMID:25182419; Pesticides:cyproconazole; Reaxys:8324780
G
Aass
aminoadipate-semialdehyde synthase
decreases expression
ISO
cyproconazole results in decreased expression of AASS mRNA
CTD
PMID:22334560
NCBI chr 4:51,606,461...51,663,136
Ensembl chr 4:51,606,462...51,663,136
G
Abcb11
ATP binding cassette subfamily B member 11
multiple interactions
EXP
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ABCB11 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of ABCB11 mRNA
CTD
PMID:29038839
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Abcb1a
ATP binding cassette subfamily B member 1A
increases expression multiple interactions
EXP ISO
cyproconazole results in increased expression of ABCB1A mRNA; cyproconazole results in increased expression of ABCB1A protein [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ABCB1A mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of ABCB1A mRNA
CTD
PMID:25182419 PMID:29038839 PMID:33150952
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcb1b
ATP-binding cassette, sub-family B member 1B
increases expression
EXP
cyproconazole results in increased expression of ABCB1B mRNA
CTD
PMID:25182419
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
G
Abcc2
ATP binding cassette subfamily C member 2
increases expression multiple interactions
ISO EXP
cyproconazole results in increased expression of ABCC2 mRNA [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ABCC2 mRNA
CTD
PMID:28058446 PMID:29038839
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Abcc3
ATP binding cassette subfamily C member 3
increases expression multiple interactions
ISO EXP
cyproconazole results in increased expression of ABCC3 mRNA; cyproconazole results in increased expression of ABCC3 protein [NR1I2 protein co-treated with NR1I3 protein] affects the reaction [cyproconazole results in increased expression of ABCC3 mRNA]; [NR1I2 protein co-treated with NR1I3 protein] affects the reaction [cyproconazole results in increased expression of ABCC3 protein] [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ABCC3 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of ABCC3 mRNA
CTD
PMID:22334560 PMID:28058446 PMID:29038839 PMID:33150952
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
G
Abcc4
ATP binding cassette subfamily C member 4
increases expression
ISO
cyproconazole results in increased expression of ABCC4 mRNA
CTD
PMID:22334560 PMID:23970803
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
G
Abhd4
abhydrolase domain containing 4, N-acyl phospholipase B
increases expression
ISO
cyproconazole results in increased expression of ABHD4 mRNA
CTD
PMID:22334560
NCBI chr15:27,697,384...27,716,013
Ensembl chr15:27,704,113...27,716,966
G
Abl1
ABL proto-oncogene 1, non-receptor tyrosine kinase
multiple interactions
EXP
[cyproconazole co-treated with epoxiconazole] results in increased expression of ABL1 mRNA
CTD
PMID:29038839
NCBI chr 3:14,979,853...15,083,065
Ensembl chr 3:14,979,853...15,083,065
G
Acaa2
acetyl-CoA acyltransferase 2
decreases expression
ISO
cyproconazole results in decreased expression of ACAA2 mRNA
CTD
PMID:22334560
NCBI chr18:68,345,136...68,373,246
Ensembl chr18:68,345,012...68,373,249
G
Acat1
acetyl-CoA acetyltransferase 1
decreases expression
ISO
cyproconazole results in decreased expression of ACAT1 mRNA
CTD
PMID:22334560
NCBI chr 8:53,979,813...54,008,861
Ensembl chr 8:53,979,813...54,008,855
G
Acat2
acetyl-CoA acetyltransferase 2
multiple interactions
EXP
[cyproconazole co-treated with epoxiconazole] results in increased expression of ACAT2 mRNA
CTD
PMID:29038839
NCBI chr 1:47,695,833...47,713,879
Ensembl chr 1:47,695,788...47,752,821
G
Acly
ATP citrate lyase
increases expression
EXP
cyproconazole results in increased expression of ACLY mRNA
CTD
PMID:29038839
NCBI chr10:85,412,045...85,464,253
Ensembl chr10:85,412,049...85,463,320
G
Aco1
aconitase 1
multiple interactions
EXP
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ACO1 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of ACO1 mRNA
CTD
PMID:29038839
NCBI chr 5:55,259,841...55,315,872
Ensembl chr 5:55,259,827...55,316,391
G
Acot3
acyl-CoA thioesterase 3
multiple interactions
EXP
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ACOT3 mRNA
CTD
PMID:29038839
NCBI chr 6:103,682,518...103,688,735
Ensembl chr 6:103,682,596...103,688,427 Ensembl chr 6:103,682,596...103,688,427
G
Acot9
acyl-CoA thioesterase 9
multiple interactions
EXP
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ACOT9 mRNA
CTD
PMID:29038839
NCBI chr X:40,073,197...40,123,573
Ensembl chr X:40,064,810...40,123,559
G
Acox1
acyl-CoA oxidase 1
decreases expression
ISO
cyproconazole results in decreased expression of ACOX1 protein
CTD
PMID:29995386
NCBI chr10:101,406,197...101,431,252
Ensembl chr10:101,406,197...101,431,232
G
Acp2
acid phosphatase 2, lysosomal
increases expression
ISO
cyproconazole results in increased expression of ACP2 mRNA
CTD
PMID:22334560
NCBI chr 3:77,175,022...77,185,180
Ensembl chr 3:77,175,895...77,185,680
G
Acsl1
acyl-CoA synthetase long-chain family member 1
decreases expression
ISO
cyproconazole results in decreased expression of ACSL1 mRNA
CTD
PMID:22334560
NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541
G
Actn1
actinin, alpha 1
decreases expression
ISO
cyproconazole results in decreased expression of ACTN1 mRNA
CTD
PMID:26238599
NCBI chr 6:98,998,553...99,093,334
Ensembl chr 6:98,998,556...99,093,251
G
Adam11
ADAM metallopeptidase domain 11
increases expression
ISO
cyproconazole results in increased expression of ADAM11 mRNA
CTD
PMID:22334560
NCBI chr10:87,724,115...87,742,773
Ensembl chr10:87,724,234...87,741,562
G
Adss1
adenylosuccinate synthase 1
increases expression
ISO
cyproconazole results in increased expression of ADSS1 mRNA
CTD
PMID:22334560
NCBI chr 6:131,679,795...131,702,012
Ensembl chr 6:131,679,701...131,701,998
G
Ahctf1
AT hook containing transcription factor 1
decreases expression
ISO
cyproconazole results in decreased expression of AHCTF1 mRNA
CTD
PMID:22334560
NCBI chr13:91,481,936...91,536,391
Ensembl chr13:91,481,936...91,536,391
G
Ahr
aryl hydrocarbon receptor
increases expression multiple interactions
ISO EXP
cyproconazole results in increased expression of AHR mRNA [NR1I2 protein co-treated with NR1I3 protein] affects the reaction [cyproconazole results in increased expression of AHR mRNA]
CTD
PMID:22334560 PMID:25182419 PMID:28058446 PMID:29038839
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Ahsg
alpha-2-HS-glycoprotein
decreases expression
ISO
cyproconazole results in decreased expression of AHSG mRNA
CTD
PMID:22334560
NCBI chr11:78,121,388...78,127,998
Ensembl chr11:78,117,918...78,145,999
G
Akap1
A-kinase anchoring protein 1
decreases expression
ISO
cyproconazole results in decreased expression of AKAP1 mRNA
CTD
PMID:22334560
NCBI chr10:73,621,021...73,654,123
Ensembl chr10:73,621,883...73,653,896
G
Akap13
A-kinase anchoring protein 13
decreases expression
ISO
cyproconazole results in decreased expression of AKAP13 mRNA
CTD
PMID:22334560
NCBI chr 1:129,313,183...129,619,647
Ensembl chr 1:129,314,402...129,619,646
G
Akap9
A-kinase anchoring protein 9
decreases expression
ISO
cyproconazole results in decreased expression of AKAP9 mRNA
CTD
PMID:22334560
NCBI chr 4:30,056,738...30,192,716
Ensembl chr 4:30,056,738...30,192,606
G
Akr1b7
aldo-keto reductase family 1, member B7
increases expression
ISO
cyproconazole results in increased expression of AKR1B7 mRNA
CTD
PMID:22334560 PMID:23970803
NCBI chr 4:63,053,560...63,100,934
Ensembl chr 4:63,076,800...63,089,502
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
increases expression multiple interactions decreases expression
EXP ISO
cyproconazole results in increased expression of ALDH1A1 mRNA [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ALDH1A1 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of ALDH1A1 mRNA cyproconazole results in decreased expression of ALDH1A1 protein
CTD
PMID:25182419 PMID:29038839 PMID:29995386
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
G
Als2
alsin Rho guanine nucleotide exchange factor ALS2
decreases expression
ISO
cyproconazole results in decreased expression of ALS2 mRNA
CTD
PMID:22334560
NCBI chr 9:60,613,182...60,686,394
Ensembl chr 9:60,613,167...60,670,737
G
Anxa7
annexin A7
increases expression
ISO
cyproconazole results in increased expression of ANXA7 mRNA
CTD
PMID:22334560
NCBI chr15:3,821,798...3,849,659
Ensembl chr15:3,821,845...3,849,385
G
Apex1
apurinic/apyrimidinic endodeoxyribonuclease 1
increases expression multiple interactions
EXP
cyproconazole results in increased expression of APEX1 mRNA [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of APEX1 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of APEX1 mRNA
CTD
PMID:29038839
NCBI chr15:24,144,595...24,146,785
Ensembl chr15:24,144,362...24,146,785
G
Apof
apolipoprotein F
multiple interactions
EXP
[cyproconazole co-treated with epoxiconazole] results in increased expression of APOF mRNA
CTD
PMID:29038839
NCBI chr 7:700,688...702,130
Ensembl chr 7:700,762...701,946
G
Arg1
arginase 1
increases expression
EXP
cyproconazole results in increased expression of ARG1 mRNA
CTD
PMID:22664269
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
G
Arhgef28
Rho guanine nucleotide exchange factor 28
increases expression
ISO
cyproconazole results in increased expression of ARHGEF28 mRNA
CTD
PMID:22045034
NCBI chr 2:29,263,888...29,560,595
Ensembl chr 2:29,263,886...29,560,672
G
Arl5a
ADP-ribosylation factor like GTPase 5A
decreases expression
ISO
cyproconazole results in decreased expression of ARL5A mRNA
CTD
PMID:22334560
NCBI chr 3:36,878,461...36,903,362
Ensembl chr 3:36,880,712...36,903,211
G
Arpp19
cAMP-regulated phosphoprotein 19
increases expression
ISO
cyproconazole results in increased expression of ARPP19 mRNA
CTD
PMID:22334560
NCBI chr 8:75,779,640...75,802,474
Ensembl chr 8:75,779,523...75,802,452 Ensembl chr 8:75,779,523...75,802,452
G
Asah1
N-acylsphingosine amidohydrolase 1
increases expression
ISO
cyproconazole results in increased expression of ASAH1 mRNA
CTD
PMID:22334560
NCBI chr16:50,966,404...50,997,827
Ensembl chr16:50,966,229...51,008,233
G
Asns
asparagine synthetase (glutamine-hydrolyzing)
multiple interactions
EXP
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ASNS mRNA
CTD
PMID:29038839
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
G
Atf5
activating transcription factor 5
decreases expression
ISO
cyproconazole results in decreased expression of ATF5 mRNA
CTD
PMID:22334560
NCBI chr 1:95,295,602...95,299,755
Ensembl chr 1:95,295,610...95,299,707
G
Atf6
activating transcription factor 6
multiple interactions
EXP
[cyproconazole co-treated with epoxiconazole] results in increased expression of ATF6 mRNA
CTD
PMID:29038839
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
G
Atg16l2
autophagy related 16-like 2
increases expression
ISO
cyproconazole results in increased expression of ATG16L2 mRNA
CTD
PMID:22334560
NCBI chr 1:155,687,386...155,703,419
Ensembl chr 1:155,684,564...155,703,420
G
Atm
ATM serine/threonine kinase
multiple interactions
EXP
[cyproconazole co-treated with epoxiconazole] results in increased expression of ATM mRNA
CTD
PMID:29038839
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
G
Atp6v0e1
ATPase H+ transporting V0 subunit e1
increases expression
ISO
cyproconazole results in increased expression of ATP6V0E mRNA
CTD
PMID:22334560
NCBI chr10:16,479,656...16,502,732
Ensembl chr10:16,479,567...16,524,434
G
Atp8b1
ATPase phospholipid transporting 8B1
increases expression multiple interactions
EXP
cyproconazole results in increased expression of ATP8B1 mRNA [cyproconazole co-treated with epoxiconazole] results in increased expression of ATP8B1 mRNA
CTD
PMID:29038839
NCBI chr18:58,016,382...58,157,213
Ensembl chr18:58,018,268...58,157,396
G
Atxn7l3b
ataxin 7-like 3B
decreases expression
ISO
cyproconazole results in decreased expression of ATXN7L3B mRNA
CTD
PMID:22334560
NCBI chr 7:48,322,451...48,325,975
Ensembl chr 7:48,321,755...48,328,878
G
Bcar1
BCAR1 scaffold protein, Cas family member
decreases expression
ISO
cyproconazole results in decreased expression of BCAR1 mRNA
CTD
PMID:26238599
NCBI chr19:39,679,215...39,713,907
Ensembl chr19:39,679,204...39,713,907
G
Bhmt2
betaine-homocysteine S-methyltransferase 2
decreases expression
ISO
cyproconazole results in decreased expression of BHMT2 mRNA
CTD
PMID:22334560
NCBI chr 2:24,895,525...24,912,475
Ensembl chr 2:24,895,533...24,912,475
G
Bid
BH3 interacting domain death agonist
decreases expression
ISO
cyproconazole results in decreased expression of BID mRNA
CTD
PMID:22334560
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
G
C2cd2
C2 calcium-dependent domain containing 2
decreases expression
ISO
cyproconazole results in decreased expression of C2CD2 mRNA
CTD
PMID:22334560
NCBI chr11:37,225,321...37,289,741
Ensembl chr11:37,227,415...37,289,739
G
C4b
complement C4B
decreases expression
ISO
cyproconazole results in decreased expression of C4B mRNA
CTD
PMID:22334560
NCBI chr20:4,197,371...4,211,684
Ensembl chr20:4,197,366...4,211,681
G
Capns1
calpain, small subunit 1
increases expression
ISO
cyproconazole results in increased expression of CAPNS1 mRNA
CTD
PMID:22334560
NCBI chr 1:85,444,613...85,454,861
Ensembl chr 1:85,444,608...85,454,795
G
Cars1
cysteinyl-tRNA synthetase 1
decreases expression
ISO
cyproconazole results in decreased expression of CARS1 mRNA
CTD
PMID:22334560
NCBI chr 1:198,753,689...198,796,016
Ensembl chr 1:198,753,691...198,795,941
G
Casp7
caspase 7
multiple interactions
EXP
[cyproconazole co-treated with epoxiconazole] results in increased expression of CASP7 mRNA
CTD
PMID:29038839
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
G
Cav1
caveolin 1
decreases expression
ISO
cyproconazole results in decreased expression of CAV1 mRNA
CTD
PMID:26238599
NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
G
Cd24
CD24 molecule
affects expression
ISO
cyproconazole affects the expression of CD24A mRNA
CTD
PMID:22045034
NCBI chr20:47,074,353...47,079,662
Ensembl chr20:47,073,512...47,079,662
G
Cd36
CD36 molecule
increases expression multiple interactions
ISO EXP
cyproconazole results in increased expression of CD36 mRNA [NR1I2 protein co-treated with NR1I3 protein] affects the reaction [cyproconazole results in increased expression of CD36 mRNA] [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of CD36 mRNA
CTD
PMID:22334560 PMID:28058446 PMID:29038839
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
G
Cdc34
cell division cycle 34, ubiqiutin conjugating enzyme
increases expression
ISO
cyproconazole results in increased expression of CDC34 mRNA
CTD
PMID:22334560
NCBI chr 7:10,017,588...10,023,586
Ensembl chr 7:10,017,588...10,023,186
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
multiple interactions increases expression
ISO EXP
[NR1I2 protein co-treated with NR1I3 protein] affects the reaction [cyproconazole results in increased expression of CDKN1A mRNA] [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in decreased expression of CDKN1A mRNA; [cyproconazole co-treated with epoxiconazole] results in decreased expression of CDKN1A mRNA
CTD
PMID:28058446 PMID:29038839
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cds2
CDP-diacylglycerol synthase 2
increases expression
ISO
cyproconazole results in increased expression of CDS2 mRNA
CTD
PMID:22334560
NCBI chr 3:119,514,963...119,553,555
Ensembl chr 3:119,515,000...119,553,541
G
Cebpz
CCAAT/enhancer binding protein zeta
decreases expression
ISO
cyproconazole results in decreased expression of CEBPZ mRNA
CTD
PMID:22334560
NCBI chr 6:16,119,871...16,137,600
Ensembl chr 6:16,119,872...16,137,600
G
Ces2c
carboxylesterase 2C
increases expression multiple interactions
EXP
cyproconazole results in increased expression of CES2C mRNA [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of CES2C mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of CES2C mRNA
CTD
PMID:25182419 PMID:29038839
NCBI chr 1:260,391,190...260,398,757
Ensembl chr 1:260,388,902...260,398,790
G
Ces2h
carboxylesterase 2H
increases expression
ISO
cyproconazole results in increased expression of CES2 mRNA cyproconazole results in increased expression of CES2 protein
CTD
PMID:22334560 PMID:29995386
NCBI chr19:32,974,242...32,988,842
Ensembl chr19:32,974,242...32,988,830
G
Cggbp1
CGG triplet repeat binding protein 1
decreases expression
ISO
cyproconazole results in decreased expression of CGGBP1 mRNA
CTD
PMID:22334560
NCBI chr11:2,565,629...2,572,869
Ensembl chr11:2,565,484...2,573,031
G
Chd1l
chromodomain helicase DNA binding protein 1-like
increases expression
ISO
cyproconazole results in increased expression of CHD1L mRNA
CTD
PMID:22334560
NCBI chr 2:185,138,526...185,217,498
Ensembl chr 2:185,139,308...185,217,595
G
Chka
choline kinase alpha
decreases expression
ISO
cyproconazole results in decreased expression of CHKA mRNA
CTD
PMID:22334560
NCBI chr 1:201,076,804...201,125,517
Ensembl chr 1:201,076,860...201,125,516
G
Cmah
cytidine monophospho-N-acetylneuraminic acid hydroxylase
decreases expression
ISO
cyproconazole results in decreased expression of CMAH mRNA
CTD
PMID:22334560
NCBI chr17:40,557,161...40,642,350
Ensembl chr17:40,583,667...40,642,275
G
Comt
catechol-O-methyltransferase
multiple interactions
EXP
[cyproconazole co-treated with epoxiconazole] results in increased expression of COMT mRNA
CTD
PMID:29038839
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
G
Cpt2
carnitine palmitoyltransferase 2
multiple interactions
EXP
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of CPT2 mRNA
CTD
PMID:29038839
NCBI chr 5:122,664,677...122,682,126
Ensembl chr 5:122,664,677...122,682,095
G
Creg1
cellular repressor of E1A-stimulated genes 1
increases expression
ISO
cyproconazole results in increased expression of CREG1 mRNA
CTD
PMID:22334560
NCBI chr13:78,019,814...78,032,310
Ensembl chr13:78,019,843...78,032,308
G
Crp
C-reactive protein
increases expression
ISO
cyproconazole results in increased expression of CRP mRNA
CTD
PMID:22334560
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
G
Ctsd
cathepsin D
increases expression
ISO
cyproconazole results in increased expression of CTSD mRNA
CTD
PMID:22334560
NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
G
Ctse
cathepsin E
multiple interactions
EXP
[cyproconazole co-treated with epoxiconazole] results in increased expression of CTSE mRNA
CTD
PMID:29038839
NCBI chr13:43,091,954...43,114,509
Ensembl chr13:43,092,128...43,114,502
G
Ctsl
cathepsin L
increases expression
ISO
cyproconazole results in increased expression of CTSL mRNA
CTD
PMID:22334560
NCBI chr17:764,370...770,533
Ensembl chr17:764,309...770,548
G
Ctso
cathepsin O
increases expression
ISO
cyproconazole results in increased expression of CTSO mRNA
CTD
PMID:22334560
NCBI chr 2:167,230,407...167,254,761
Ensembl chr 2:167,230,330...167,253,702
G
Cxcl12
C-X-C motif chemokine ligand 12
affects expression
ISO
cyproconazole affects the expression of CXCL12 mRNA
CTD
PMID:22045034
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
G
Cyb5a
cytochrome b5 type A
increases expression
ISO
cyproconazole results in increased expression of CYB5A mRNA
CTD
PMID:22334560
NCBI chr18:78,213,067...78,245,677
Ensembl chr18:78,202,342...78,258,535 Ensembl chr18:78,202,342...78,258,535
G
Cyp11b2
cytochrome P450, family 11, subfamily b, polypeptide 2
multiple interactions
EXP
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in decreased expression of CYP11B1 mRNA
CTD
PMID:28454766
NCBI chr 7:106,838,590...106,845,004
Ensembl chr 7:106,838,590...106,845,004
G
Cyp11b3
cytochrome P450, family 11, subfamily b, polypeptide 3
decreases expression
EXP
cyproconazole results in decreased expression of CYP11B2 mRNA
CTD
PMID:28454766
NCBI chr 7:106,808,559...106,814,048
Ensembl chr 7:106,808,559...106,814,048
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
multiple interactions
ISO
[prochloraz co-treated with epoxiconazole co-treated with cyproconazole] results in increased expression of CYP19A1 mRNA
CTD
PMID:25233012
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression multiple interactions
EXP ISO
cyproconazole results in increased expression of CYP1A1 mRNA cyproconazole results in increased expression of CYP1A1 mRNA; cyproconazole results in increased expression of CYP1A1 protein [epoxiconazole co-treated with cyproconazole] results in increased activity of CYP1A1 protein; [epoxiconazole co-treated with cyproconazole] results in increased expression of CYP1A1 mRNA; [prochloraz co-treated with epoxiconazole co-treated with cyproconazole] results in increased activity of CYP1A1 protein; [prochloraz co-treated with epoxiconazole co-treated with cyproconazole] results in increased expression of CYP1A1 mRNA [cyproconazole co-treated with azoxystrobin] results in increased expression of CYP1A1 mRNA
CTD
PMID:25182419 PMID:29038839 PMID:29294346 PMID:32194361 PMID:33150952
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
increases expression multiple interactions
ISO EXP
cyproconazole results in increased expression of CYP1A2 mRNA NR1I3 promotes the reaction [cyproconazole results in increased expression of CYP1A2 mRNA] cyproconazole results in increased expression of CYP1A2 mRNA; cyproconazole results in increased expression of CYP1A2 protein
CTD
PMID:22334560 PMID:25656644 PMID:29995386 PMID:33150952
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp26a1
cytochrome P450, family 26, subfamily a, polypeptide 1
increases expression
EXP
cyproconazole results in increased expression of CYP26A1 mRNA
CTD
PMID:22664269
NCBI chr 1:235,471,368...235,475,204
Ensembl chr 1:235,471,298...235,475,204
G
Cyp26b1
cytochrome P450, family 26, subfamily b, polypeptide 1
increases expression
ISO
cyproconazole results in increased expression of CYP26B1 mRNA
CTD
PMID:22045034
NCBI chr 4:117,041,808...117,058,628
Ensembl chr 4:117,041,808...117,058,628
G
Cyp2b1
cytochrome P450, family 2, subfamily b, polypeptide 1
increases expression increases activity multiple interactions
EXP
cyproconazole results in increased expression of CYP2B1 mRNA cyproconazole results in increased activity of CYP2B1 protein [cyproconazole co-treated with epoxiconazole] results in increased expression of CYP2B1 mRNA; [epoxiconazole co-treated with cyproconazole] results in increased activity of CYP2B1 protein; [prochloraz co-treated with epoxiconazole co-treated with cyproconazole] results in increased activity of CYP2B1 protein; [prochloraz co-treated with epoxiconazole co-treated with cyproconazole] results in increased expression of CYP2B1 mRNA
CTD
PMID:25182419 PMID:29038839
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
G
Cyp2b15
cytochrome P450, family 2, subfamily b, polypeptide 15
increases expression
EXP
cyproconazole results in increased expression of CYP2B15 mRNA
CTD
PMID:25182419
NCBI chr 1:82,094,188...82,106,492
Ensembl chr 1:82,094,180...82,106,492
G
Cyp2b2
cytochrome P450, family 2, subfamily b, polypeptide 2
multiple interactions increases expression
EXP
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of CYP2B2 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of CYP2B2 mRNA cyproconazole results in increased expression of CYP2B2 mRNA
CTD
PMID:29038839
NCBI chr 1:81,594,534...81,608,567
Ensembl chr 1:81,594,555...81,608,566
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
multiple interactions increases expression
ISO
[cyproconazole co-treated with azoxystrobin] results in increased expression of CYP2B6 protein; [NR1I2 protein co-treated with NR1I3 protein] affects the reaction [cyproconazole results in increased expression of CYP2B10 protein]; [NR1I3 protein co-treated with NR1I2 protein] affects the reaction [cyproconazole results in increased expression of CYP2B10 mRNA] cyproconazole results in increased expression of CYP2B6 mRNA; cyproconazole results in increased expression of CYP2B6 protein cyproconazole results in increased expression of CYP2B10 mRNA; cyproconazole results in increased expression of CYP2B10 protein NR1I3 promotes the reaction [cyproconazole results in increased expression of CYP2B10 mRNA]; NR1I3 protein mutant form inhibits the reaction [cyproconazole results in increased expression of CYP2B10 mRNA]; NR1I3 protein mutant form inhibits the reaction [cyproconazole results in increased expression of CYP2B10 protein]
CTD
PMID:17557908 PMID:22334560 PMID:23970803 PMID:25656644 PMID:28058446 PMID:29294346 PMID:29995386 PMID:33150952 More...
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
G
Cyp2c13
cytochrome P450, family 2, subfamily c, polypeptide 13
increases expression
EXP
cyproconazole results in increased expression of CYP2C13 protein
CTD
PMID:33150952
NCBI chr 1:238,786,764...238,867,195
Ensembl chr 1:238,786,765...238,867,191
G
Cyp2c24
cytochrome P450, family 2, subfamily c, polypeptide 24
increases expression
ISO EXP
cyproconazole results in increased expression of CYP2C55 mRNA; cyproconazole results in increased expression of CYP2C55 protein
CTD
PMID:22334560 PMID:23970803 PMID:33150952
NCBI chr 1:236,873,967...236,936,238
Ensembl chr 1:236,873,967...236,936,238
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
increases expression
EXP ISO
cyproconazole results in increased expression of CYP2C6 mRNA cyproconazole results in increased expression of CYP2C19 protein cyproconazole results in increased expression of CYP2C29 protein
CTD
PMID:25182419 PMID:32194361 PMID:33150952
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
multiple interactions decreases expression increases expression
EXP ISO
[cyproconazole co-treated with epoxiconazole] results in increased expression of CYP2E1 mRNA cyproconazole results in decreased expression of CYP2E1 mRNA cyproconazole results in decreased expression of CYP2E1 protein cyproconazole results in increased expression of CYP2E1 protein
CTD
PMID:29038839 PMID:29995386 PMID:33150952
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Cyp3a18
cytochrome P450, family 3, subfamily a, polypeptide 18
increases expression
EXP
cyproconazole results in increased expression of CYP3A18 protein
CTD
PMID:33150952
NCBI chr12:8,880,509...8,930,382
Ensembl chr12:8,880,528...8,930,381
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions increases expression
EXP ISO
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of CYP3A2 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of CYP3A2 mRNA cyproconazole results in increased expression of CYP3A4 mRNA; cyproconazole results in increased expression of CYP3A4 protein [Amiodarone co-treated with Benzoic Acid co-treated with cyproconazole co-treated with flusilazole co-treated with enilconazole co-treated with prochloraz co-treated with propiconazole co-treated with tebuconazole] results in increased expression of CYP3A4 protein; [azoxystrobin co-treated with cyproconazole] results in increased expression of CYP3A4 protein; [cyproconazole co-treated with azoxystrobin] results in increased expression of CYP3A4 mRNA
CTD
PMID:29038839 PMID:29294346 PMID:29995386 PMID:33150952 PMID:34273450
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Cyp3a23-3a1
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1
increases expression increases activity multiple interactions
EXP
cyproconazole results in increased expression of CYP3A23-3A1 mRNA cyproconazole results in increased activity of CYP3A23-3A1 protein [cyproconazole co-treated with epoxiconazole] results in increased expression of CYP3A23-3A1 mRNA; [epoxiconazole co-treated with cyproconazole] results in increased activity of CYP3A23-3A1 protein; [prochloraz co-treated with cyproconazole co-treated with epoxiconazole] results in increased expression of CYP3A23-3A1 mRNA; [prochloraz co-treated with epoxiconazole co-treated with cyproconazole] results in increased activity of CYP3A23-3A1 protein
CTD
PMID:25182419 PMID:29038839
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030 Ensembl chr12:9,254,475...9,285,030
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
increases expression
EXP
cyproconazole results in increased expression of CYP3A9 protein
CTD
PMID:33150952
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
G
Cyp51
cytochrome P450, family 51
affects expression decreases activity
ISO
cyproconazole affects the expression of CYP51 mRNA cyproconazole results in decreased activity of CYP51A1 protein
CTD
PMID:16989930 PMID:22045034
NCBI chr 4:30,036,956...30,055,410
Ensembl chr 4:30,036,865...30,055,410
G
Cyp7a1
cytochrome P450 family 7 subfamily A member 1
multiple interactions decreases expression
EXP ISO
[cyproconazole co-treated with epoxiconazole] results in increased expression of CYP7A1 mRNA cyproconazole results in decreased expression of CYP7A1 mRNA
CTD
PMID:29038839 PMID:29995386
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
G
Dbt
dihydrolipoamide branched chain transacylase E2
decreases expression
ISO
cyproconazole results in decreased expression of DBT mRNA
CTD
PMID:22334560
NCBI chr 2:204,481,744...204,510,612
Ensembl chr 2:204,481,737...204,510,609
G
Ddost
dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit
increases expression
ISO
cyproconazole results in increased expression of DDOST mRNA
CTD
PMID:22334560
NCBI chr 5:150,522,297...150,529,413
Ensembl chr 5:150,522,242...150,529,413
G
Ddx46
DEAD-box helicase 46
decreases expression
ISO
cyproconazole results in decreased expression of DDX46 mRNA
CTD
PMID:22334560
NCBI chr17:8,942,070...8,988,440
Ensembl chr17:8,944,454...8,988,439
G
Ddx6
DEAD-box helicase 6
decreases expression
ISO
cyproconazole results in decreased expression of DDX6 mRNA
CTD
PMID:22334560 PMID:23970803
NCBI chr 8:44,931,127...44,967,773
Ensembl chr 8:44,931,974...44,964,405
G
Dexi
Dexi homolog
decreases expression
ISO
cyproconazole results in decreased expression of DEXI mRNA
CTD
PMID:22334560
NCBI chr10:5,126,021...5,138,746
Ensembl chr10:5,137,288...5,138,738
G
Dhrs3
dehydrogenase/reductase 3
increases expression
EXP
cyproconazole results in increased expression of DHRS3 mRNA
CTD
PMID:22664269
NCBI chr 5:156,747,939...156,782,420
Ensembl chr 5:156,747,962...156,782,417
G
Diablo
diablo, IAP-binding mitochondrial protein
increases expression multiple interactions
EXP
cyproconazole results in increased expression of DIABLO mRNA [cyproconazole co-treated with epoxiconazole] results in increased expression of DIABLO mRNA
CTD
PMID:29038839
NCBI chr12:33,055,784...33,070,401
Ensembl chr12:33,055,263...33,070,387
G
Dlx5
distal-less homeobox 5
decreases expression
ISO
cyproconazole results in decreased expression of DLX5 mRNA
CTD
PMID:22045034
NCBI chr 4:34,999,139...35,003,504
Ensembl chr 4:34,999,139...35,003,407
G
Dmgdh
dimethylglycine dehydrogenase
decreases expression
ISO
cyproconazole results in decreased expression of DMGDH mRNA
CTD
PMID:22334560
NCBI chr 2:24,912,600...24,987,533
Ensembl chr 2:24,912,578...24,987,528
G
Dnai1
dynein, axonemal, intermediate chain 1
decreases expression
ISO
cyproconazole results in decreased expression of DNAI1 mRNA
CTD
PMID:22334560 PMID:23970803
NCBI chr 5:56,730,179...56,800,926
Ensembl chr 5:56,730,179...56,800,925
G
Dpagt1
dolichyl-phosphate N-acetylglucosaminephosphotransferase 1
increases expression
ISO
cyproconazole results in increased expression of DPAGT1 mRNA
CTD
PMID:22334560
NCBI chr 8:44,664,055...44,671,102
Ensembl chr 8:44,664,071...44,671,087
G
Dusp3
dual specificity phosphatase 3
increases expression
ISO
cyproconazole results in increased expression of DUSP3 mRNA
CTD
PMID:22334560
NCBI chr10:86,920,014...86,933,739
Ensembl chr10:86,920,014...86,933,962
G
Dusp5
dual specificity phosphatase 5
increases expression
EXP
cyproconazole results in increased expression of DUSP5 mRNA
CTD
PMID:22664269
NCBI chr 1:252,538,408...252,555,320
Ensembl chr 1:252,538,449...252,551,818
G
Egr2
early growth response 2
decreases expression
EXP
cyproconazole results in decreased expression of EGR2 mRNA
CTD
PMID:22664269
NCBI chr20:21,051,270...21,056,322
Ensembl chr20:21,051,277...21,055,562
G
Ehhadh
enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase
multiple interactions
EXP
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of EHHADH mRNA
CTD
PMID:29038839
NCBI chr11:79,241,927...79,275,173
Ensembl chr11:79,241,938...79,275,188
G
Eif2ak3
eukaryotic translation initiation factor 2 alpha kinase 3
multiple interactions
EXP
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of EIF2AK3 mRNA
CTD
PMID:29038839
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
G
Eif4g2
eukaryotic translation initiation factor 4, gamma 2
decreases expression
ISO
cyproconazole results in decreased expression of EIF4G2 mRNA
CTD
PMID:22334560
NCBI chr 1:165,181,433...165,193,583
Ensembl chr 1:165,181,434...165,193,588
G
Elovl1
ELOVL fatty acid elongase 1
increases expression
ISO
cyproconazole results in increased expression of ELOVL1 mRNA
CTD
PMID:22334560
NCBI chr 5:131,961,478...131,965,961
Ensembl chr 5:131,961,322...131,965,958
G
Enho
energy homeostasis associated
decreases expression
ISO
cyproconazole results in decreased expression of ENHO mRNA
CTD
PMID:22334560
NCBI chr 5:56,800,980...56,802,777
Ensembl chr 5:56,800,980...56,802,777
G
Entpd5
ectonucleoside triphosphate diphosphohydrolase 5
increases expression
ISO
cyproconazole results in increased expression of ENTPD5 mRNA
CTD
PMID:22334560
NCBI chr 6:104,019,095...104,055,311
Ensembl chr 6:104,019,185...104,055,530
G
Ep300
E1A binding protein p300
multiple interactions
EXP
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of EP300 mRNA
CTD
PMID:29038839
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
G
Epha2
Eph receptor A2
decreases expression
ISO
cyproconazole results in decreased expression of EPHA2 mRNA
CTD
PMID:22045034
NCBI chr 5:153,605,644...153,634,115
Ensembl chr 5:153,605,644...153,634,117
G
Ephx1
epoxide hydrolase 1
increases expression multiple interactions
ISO EXP
cyproconazole results in increased expression of EPHX1 mRNA [cyproconazole co-treated with epoxiconazole] results in increased expression of EPHX1 mRNA
CTD
PMID:22334560 PMID:29038839
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
G
Ephx2
epoxide hydrolase 2
decreases expression
ISO
cyproconazole results in decreased expression of EPHX2 mRNA
CTD
PMID:22334560
NCBI chr15:40,289,901...40,327,632
Ensembl chr15:40,289,902...40,327,615
G
Ercc1
ERCC excision repair 1, endonuclease non-catalytic subunit
multiple interactions
EXP
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ERCC1 mRNA
CTD
PMID:29038839
NCBI chr 1:78,971,310...79,007,963
Ensembl chr 1:78,996,390...79,007,963
G
Esrrb
estrogen-related receptor beta
decreases expression
ISO
cyproconazole results in decreased expression of ESRRB mRNA
CTD
PMID:22045034
NCBI chr 6:106,007,701...106,163,136
Ensembl chr 6:106,008,095...106,160,791
G
Etfa
electron transfer flavoprotein subunit alpha
decreases expression
ISO
cyproconazole results in decreased expression of ETFA mRNA
CTD
PMID:22334560
NCBI chr 8:55,835,115...55,891,890
Ensembl chr 8:55,835,134...55,891,969
G
Etnppl
ethanolamine-phosphate phospho-lyase
decreases expression
ISO
cyproconazole results in decreased expression of ETNPPL mRNA
CTD
PMID:22334560
NCBI chr 2:219,173,048...219,194,646
Ensembl chr 2:219,172,978...219,192,212
G
Etv4
ETS variant transcription factor 4
decreases expression
ISO
cyproconazole results in decreased expression of ETV4 mRNA
CTD
PMID:22045034
NCBI chr10:86,706,749...86,721,974
Ensembl chr10:86,706,749...86,721,974
G
Exosc8
exosome component 8
increases expression
ISO
cyproconazole results in increased expression of EXOSC8 mRNA
CTD
PMID:22334560
NCBI chr 2:138,930,405...138,937,009
Ensembl chr 2:138,930,405...138,936,928
G
F10
coagulation factor X
increases expression
ISO
cyproconazole results in increased expression of F10 mRNA
CTD
PMID:22334560
NCBI chr16:76,468,834...76,488,141
Ensembl chr16:76,468,838...76,488,141
G
F5
coagulation factor V
decreases expression
ISO
cyproconazole results in decreased expression of F5 mRNA
CTD
PMID:22334560
NCBI chr13:76,513,509...76,583,106
Ensembl chr13:76,513,255...76,582,317
G
Fah
fumarylacetoacetate hydrolase
decreases expression
ISO
cyproconazole results in decreased expression of FAH mRNA
CTD
PMID:22334560
NCBI chr 1:138,548,830...138,571,599
Ensembl chr 1:138,548,834...138,571,505
G
Fam114a1
family with sequence similarity 114, member A1
increases expression
ISO
cyproconazole results in increased expression of FAM114A1 mRNA
CTD
PMID:22334560
NCBI chr14:43,275,693...43,346,154
Ensembl chr14:43,275,701...43,346,174
G
Fam168a
family with sequence similarity 168, member A
decreases expression
ISO
cyproconazole results in decreased expression of FAM168A mRNA
CTD
PMID:22334560
NCBI chr 1:155,057,352...155,203,439
Ensembl chr 1:155,057,352...155,201,220
G
Fas
Fas cell surface death receptor
increases expression multiple interactions
EXP
cyproconazole results in increased expression of FAS mRNA [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of FAS mRNA
CTD
PMID:29038839
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Fasn
fatty acid synthase
increases expression decreases expression
EXP ISO
cyproconazole results in increased expression of FASN mRNA cyproconazole results in decreased expression of FASN mRNA; cyproconazole results in decreased expression of FASN protein
CTD
PMID:29038839 PMID:29995386
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
G
Fbn2
fibrillin 2
increases expression
ISO
cyproconazole results in increased expression of FBN2 mRNA
CTD
PMID:22045034
NCBI chr18:51,499,670...51,703,976
Ensembl chr18:51,499,737...51,703,976
G
Fdft1
farnesyl diphosphate farnesyl transferase 1
affects expression
ISO
cyproconazole affects the expression of FDFT1 mRNA
CTD
PMID:22045034
NCBI chr15:37,412,143...37,440,198
Ensembl chr15:37,412,146...37,440,287
G
Fdps
farnesyl diphosphate synthase
affects expression
ISO
cyproconazole affects the expression of FDPS mRNA
CTD
PMID:22045034
NCBI chr 2:174,497,402...174,507,031
Ensembl chr 2:174,486,665...174,507,776
G
Fez2
fasciculation and elongation protein zeta 2
increases expression
ISO
cyproconazole results in increased expression of FEZ2 mRNA
CTD
PMID:22334560
NCBI chr 6:16,654,572...16,694,628
Ensembl chr 6:16,654,614...16,694,626
G
Fgf1
fibroblast growth factor 1
decreases expression
ISO
cyproconazole results in decreased expression of FGF1 mRNA
CTD
PMID:22334560
NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357
G
Foxa2
forkhead box A2
increases expression
ISO
cyproconazole results in increased expression of FOXA2 mRNA
CTD
PMID:22045034
NCBI chr 3:135,470,123...135,474,326
Ensembl chr 3:135,470,131...135,474,326
G
Foxg1
forkhead box G1
increases expression
ISO
cyproconazole results in increased expression of FOXG1 mRNA
CTD
PMID:22045034
NCBI chr 6:66,674,797...66,677,611
Ensembl chr 6:66,666,587...66,678,607
G
G3bp2
G3BP stress granule assembly factor 2
increases expression
ISO
cyproconazole results in increased expression of G3BP2 mRNA
CTD
PMID:22334560
NCBI chr14:15,932,403...16,020,555
Ensembl chr14:15,987,417...16,020,548
G
Gad1
glutamate decarboxylase 1
decreases expression
EXP
cyproconazole results in decreased expression of GAD1 mRNA
CTD
PMID:25182419
NCBI chr 3:55,369,704...55,410,335
Ensembl chr 3:55,369,704...55,410,333
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
increases expression
ISO
cyproconazole results in increased expression of GADD45 mRNA
CTD
PMID:28058446
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
G
Gadd45b
growth arrest and DNA-damage-inducible, beta
multiple interactions increases expression
ISO
NR1I3 protein mutant form inhibits the reaction [cyproconazole results in increased expression of GADD45B mRNA]
CTD
PMID:17557908 PMID:22334560 PMID:23970803 PMID:25656644
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
G
Gch1
GTP cyclohydrolase 1
increases expression
ISO
cyproconazole results in increased expression of GCH1 mRNA
CTD
PMID:22334560
NCBI chr15:20,404,267...20,437,727
Ensembl chr15:20,402,527...20,437,698
G
Gfra3
GDNF family receptor alpha 3
affects expression
ISO
cyproconazole affects the expression of GFRA3 mRNA
CTD
PMID:22045034
NCBI chr18:26,297,828...26,326,105
Ensembl chr18:26,297,829...26,326,105
G
Ghr
growth hormone receptor
decreases expression
ISO
cyproconazole results in decreased expression of GHR mRNA
CTD
PMID:22334560
NCBI chr 2:52,541,452...52,804,960
Ensembl chr 2:52,542,594...52,804,735
G
Gjb5
gap junction protein, beta 5
decreases expression
ISO
cyproconazole results in decreased expression of GJB5 mRNA
CTD
PMID:22045034
NCBI chr 5:139,680,670...139,683,588
Ensembl chr 5:139,680,671...139,683,583
G
Gli2
GLI family zinc finger 2
affects expression
ISO
cyproconazole affects the expression of GLI2 mRNA
CTD
PMID:22045034
NCBI chr13:29,946,882...30,163,589
Ensembl chr13:29,946,809...30,163,574
G
Glrx
glutaredoxin
increases expression
ISO
cyproconazole results in increased expression of GLRX mRNA
CTD
PMID:22334560
NCBI chr 2:5,341,873...5,351,686
Ensembl chr 2:5,341,885...5,351,680
G
Glrx5
glutaredoxin 5
increases expression
ISO
cyproconazole results in increased expression of GLRX5 mRNA
CTD
PMID:22334560
NCBI chr 6:123,988,461...123,998,545
Ensembl chr 6:123,988,134...123,998,545
G
Gls2
glutaminase 2
decreases expression
ISO
cyproconazole results in decreased expression of GLS2 mRNA
CTD
PMID:22334560
NCBI chr 7:617,252...633,424
Ensembl chr 7:617,288...633,426
G
Glud1
glutamate dehydrogenase 1
decreases expression
ISO
cyproconazole results in decreased expression of GLUD1 mRNA
CTD
PMID:22334560
NCBI chr16:9,640,312...9,673,961
Ensembl chr16:9,640,312...9,673,957
G
Gpd1
glycerol-3-phosphate dehydrogenase 1
decreases expression
ISO
cyproconazole results in decreased expression of GPD1 protein
CTD
PMID:29995386
NCBI chr 7:130,842,526...130,851,530
Ensembl chr 7:130,844,138...130,851,529
G
Gpx2
glutathione peroxidase 2
decreases expression increases expression multiple interactions
EXP
cyproconazole results in decreased expression of GPX2 mRNA cyproconazole results in increased expression of GPX2 mRNA [cyproconazole co-treated with epoxiconazole] results in increased expression of GPX2 mRNA
CTD
PMID:25182419 PMID:29038839
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
G
Gpx4
glutathione peroxidase 4
increases expression
ISO
cyproconazole results in increased expression of GPX4 mRNA
CTD
PMID:22334560
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
G
Grn
granulin precursor
increases expression
ISO
cyproconazole results in increased expression of GRN mRNA
CTD
PMID:22334560
NCBI chr10:87,387,672...87,393,777
Ensembl chr10:87,387,638...87,393,775
G
Gsr
glutathione-disulfide reductase
increases expression
EXP
cyproconazole results in increased expression of GSR mRNA
CTD
PMID:25182419
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Gsta2
glutathione S-transferase alpha 2
increases expression
ISO
cyproconazole results in increased expression of GSTA2 mRNA
CTD
PMID:22334560
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
G
Gsta5
glutathione S-transferase alpha 5
increases expression multiple interactions
EXP
cyproconazole results in increased expression of GSTA5 mRNA [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of GSTA5 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of GSTA5 mRNA
CTD
PMID:29038839
NCBI chr 8:79,105,561...79,117,472
Ensembl chr 8:79,105,661...79,117,472
G
Gstm1
glutathione S-transferase mu 1
increases expression
EXP ISO
cyproconazole results in increased expression of GSTM1 mRNA
CTD
PMID:22334560 PMID:25182419
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
G
Gstm2
glutathione S-transferase mu 2
increases expression
EXP ISO
cyproconazole results in increased expression of GSTM2 mRNA
CTD
PMID:22334560 PMID:25182419
NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961
G
Gstm4
glutathione S-transferase mu 4
increases expression
ISO
cyproconazole results in increased expression of GSTM4 mRNA
CTD
PMID:22334560
NCBI chr 2:195,667,940...195,685,315
Ensembl chr 2:195,680,004...195,685,323
G
Gstm5
glutathione S-transferase, mu 5
increases expression
ISO
cyproconazole results in increased expression of GSTM3 mRNA
CTD
PMID:22334560 PMID:23970803
NCBI chr 2:195,531,599...195,534,562
Ensembl chr 2:195,531,495...195,534,553
G
Gstt1
glutathione S-transferase theta 1
increases expression
ISO
cyproconazole results in increased expression of GSTT1 mRNA
CTD
PMID:22334560
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
G
Haao
3-hydroxyanthranilate 3,4-dioxygenase
decreases expression
ISO
cyproconazole results in decreased expression of HAAO mRNA cyproconazole results in decreased expression of HAAO protein
CTD
PMID:22334560 PMID:29995386
NCBI chr 6:10,845,235...10,864,863
Ensembl chr 6:10,845,771...10,864,877
G
Hacd1
3-hydroxyacyl-CoA dehydratase 1
increases expression
ISO
cyproconazole results in increased expression of HACD1 mRNA
CTD
PMID:22334560
NCBI chr17:77,081,508...77,106,114
Ensembl chr17:77,083,740...77,106,073
G
Hadha
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha
multiple interactions
EXP
[cyproconazole co-treated with epoxiconazole] results in increased expression of HADHA mRNA
CTD
PMID:29038839
NCBI chr 6:26,187,969...26,227,605
Ensembl chr 6:26,187,956...26,227,869
G
Hal
histidine ammonia lyase
decreases expression
ISO
cyproconazole results in decreased expression of HAL mRNA
CTD
PMID:22334560
NCBI chr 7:28,007,449...28,037,701
Ensembl chr 7:28,006,972...28,037,701
G
Hao1
hydroxyacid oxidase 1
decreases expression
ISO
cyproconazole results in decreased expression of HAO1 mRNA
CTD
PMID:22334560
NCBI chr 3:121,757,400...121,828,721
Ensembl chr 3:121,771,836...121,828,721
G
Hectd1
HECT domain E3 ubiquitin protein ligase 1
decreases expression increases expression
ISO
cyproconazole results in decreased expression of HECTD1 mRNA cyproconazole results in increased expression of HECTD1 mRNA
CTD
PMID:22045034 PMID:22334560
NCBI chr 6:69,181,429...69,268,045
Ensembl chr 6:69,181,436...69,268,053
G
Hectd2
HECT domain E3 ubiquitin protein ligase 2
decreases expression
ISO
cyproconazole results in decreased expression of HECTD2 mRNA
CTD
PMID:22334560
NCBI chr 1:234,274,967...234,345,598
Ensembl chr 1:234,275,705...234,343,487
G
Herpud1
homocysteine inducible ER protein with ubiquitin like domain 1
multiple interactions
EXP
[cyproconazole co-treated with epoxiconazole] results in increased expression of HERPUD1 mRNA
CTD
PMID:29038839
NCBI chr19:10,598,411...10,609,002
Ensembl chr19:10,598,417...10,618,424
G
Higd1c
HIG1 hypoxia inducible domain family, member 1C
increases expression
ISO
cyproconazole results in increased expression of HIGD1C mRNA
CTD
PMID:22334560
NCBI chr 7:131,477,730...131,498,853
Ensembl chr 7:131,478,519...131,498,214
G
Hist1h2bc
histone cluster 1, H2bc
decreases expression
ISO
cyproconazole results in decreased expression of H2BC21 mRNA
CTD
PMID:22334560
NCBI chr17:42,692,335...42,696,601
Ensembl chr17:42,694,723...42,696,642
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
affects expression
ISO
cyproconazole affects the expression of HMGCR mRNA
CTD
PMID:22045034
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
G
Hmgn1
high mobility group nucleosome binding domain 1
increases expression
ISO
cyproconazole results in increased expression of HMGN1 mRNA
CTD
PMID:22334560
NCBI chr11:35,422,328...35,428,247
Ensembl chr11:35,422,328...35,428,254
G
Hoxb4
homeo box B4
increases expression
ISO
cyproconazole results in increased expression of HOXB4 mRNA
CTD
PMID:22045034
NCBI chr10:81,284,552...81,287,134
Ensembl chr10:81,284,552...81,287,128
G
Hoxb5
homeo box B5
increases expression
ISO
cyproconazole results in increased expression of HOXB5 mRNA
CTD
PMID:22045034
NCBI chr10:81,269,372...81,271,580
Ensembl chr10:81,269,372...81,271,580
G
Hoxc4
homeo box C4
increases expression
ISO
cyproconazole results in increased expression of HOXC4 mRNA
CTD
PMID:22045034
NCBI chr 7:134,135,279...134,173,133
Ensembl chr 7:134,170,591...134,173,133
G
Hprt1
hypoxanthine phosphoribosyltransferase 1
decreases expression increases expression
ISO
cyproconazole results in decreased expression of HPRT1 mRNA cyproconazole results in increased expression of HPRT1 mRNA
CTD
PMID:22045034 PMID:22334560
NCBI chr X:132,736,175...132,768,149
Ensembl chr X:132,736,096...132,768,154
G
Hsd17b7
hydroxysteroid (17-beta) dehydrogenase 7
affects expression
ISO
cyproconazole affects the expression of HSD17B7 mRNA
CTD
PMID:22045034
NCBI chr13:82,170,079...82,190,018
Ensembl chr13:82,173,179...82,190,017
G
Hspa13
heat shock protein family A (Hsp70) member 13
increases expression
ISO
cyproconazole results in increased expression of HSPA13 mRNA
CTD
PMID:22334560
NCBI chr11:14,375,669...14,389,853
Ensembl chr11:14,373,275...14,389,895
G
Hspb8
heat shock protein family B (small) member 8
multiple interactions
EXP
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of HSPB8 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of HSPB8 mRNA
CTD
PMID:29038839
NCBI chr12:40,176,405...40,205,002
Ensembl chr12:40,176,532...40,191,185
G
Idi1
isopentenyl-diphosphate delta isomerase 1
increases expression
ISO
cyproconazole results in increased expression of IDI1 mRNA
CTD
PMID:22045034
NCBI chr17:61,629,592...61,637,357
Ensembl chr17:61,629,594...61,637,357
G
Ifnar2
interferon alpha and beta receptor subunit 2
increases expression
ISO
cyproconazole results in increased expression of IFNAR2 mRNA
CTD
PMID:22334560
NCBI chr11:30,613,576...30,645,958
Ensembl chr11:30,613,767...30,668,124
G
Igf1
insulin-like growth factor 1
decreases expression
ISO
cyproconazole results in decreased expression of IGF1 mRNA
CTD
PMID:22334560
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
G
Igfals
insulin-like growth factor binding protein, acid labile subunit
decreases expression
ISO
cyproconazole results in decreased expression of IGFALS mRNA
CTD
PMID:22334560
NCBI chr10:13,897,468...13,903,920
Ensembl chr10:13,898,395...13,902,677
G
Ikbke
inhibitor of nuclear factor kappa B kinase subunit epsilon
increases expression
ISO
cyproconazole results in increased expression of IKBKE mRNA
CTD
PMID:22334560
NCBI chr13:42,712,154...42,738,470
Ensembl chr13:42,712,159...42,737,143
G
Il1rap
interleukin 1 receptor accessory protein
decreases expression
ISO
cyproconazole results in decreased expression of IL1RAP mRNA
CTD
PMID:22334560
NCBI chr11:74,062,999...74,199,530
Ensembl chr11:74,070,304...74,199,530
G
Impact
impact RWD domain protein
increases expression
ISO
cyproconazole results in increased expression of IMPACT mRNA
CTD
PMID:22334560
NCBI chr18:4,108,872...4,147,571
Ensembl chr18:4,108,853...4,147,569
G
Impdh2
inosine monophosphate dehydrogenase 2
decreases expression
ISO
cyproconazole results in decreased expression of IMPDH2 mRNA
CTD
PMID:22334560
NCBI chr 8:109,256,705...109,261,365
Ensembl chr 8:109,256,728...109,261,359
G
Insig1
insulin induced gene 1
increases expression
ISO
cyproconazole results in increased expression of INSIG1 mRNA
CTD
PMID:22045034
NCBI chr 4:7,315,494...7,323,972
Ensembl chr 4:7,315,495...7,323,952
G
Irf6
interferon regulatory factor 6
increases expression
EXP
cyproconazole results in increased expression of IRF6 mRNA
CTD
PMID:22664269
NCBI chr13:104,672,179...104,691,386
Ensembl chr13:104,672,179...104,691,386
G
Itga8
integrin subunit alpha 8
increases expression
ISO
cyproconazole results in increased expression of ITGA8 mRNA
CTD
PMID:22045034
NCBI chr17:75,304,004...75,501,510
Ensembl chr17:75,304,008...75,501,510
G
Itgax
integrin subunit alpha X
multiple interactions
EXP
[cyproconazole co-treated with epoxiconazole] results in increased expression of ITGAX mRNA
CTD
PMID:29038839
NCBI chr 1:182,709,653...182,740,709
Ensembl chr 1:182,719,609...182,740,698
G
Itih1
inter-alpha trypsin inhibitor, heavy chain 1
decreases expression
ISO
cyproconazole results in decreased expression of ITIH1 mRNA
CTD
PMID:22334560
NCBI chr16:6,122,246...6,136,363
Ensembl chr16:6,122,248...6,136,363
G
Itih2
inter-alpha-trypsin inhibitor heavy chain 2
decreases expression
ISO
cyproconazole results in decreased expression of ITIH2 mRNA
CTD
PMID:22334560
NCBI chr17:68,375,574...68,411,849
Ensembl chr17:68,375,567...68,411,841
G
Itih3
inter-alpha trypsin inhibitor, heavy chain 3
decreases expression
ISO
cyproconazole results in decreased expression of ITIH3 mRNA
CTD
PMID:22334560
NCBI chr16:6,101,922...6,117,154
Ensembl chr16:6,101,930...6,116,924
G
Itm2c
integral membrane protein 2C
increases expression
ISO
cyproconazole results in increased expression of ITM2C mRNA
CTD
PMID:22334560
NCBI chr 9:86,545,927...86,559,745
Ensembl chr 9:86,545,921...86,559,742
G
Khk
ketohexokinase
decreases expression
ISO
cyproconazole results in decreased expression of KHK protein
CTD
PMID:29995386
NCBI chr 6:25,445,298...25,455,834
Ensembl chr 6:25,445,300...25,455,717
G
Ldha
lactate dehydrogenase A
decreases expression
ISO
cyproconazole results in decreased expression of LDHA mRNA
CTD
PMID:22334560
NCBI chr 1:97,371,823...97,381,247
Ensembl chr 1:97,366,021...97,433,472
G
Ldlr
low density lipoprotein receptor
affects expression
ISO
cyproconazole affects the expression of LDLR mRNA
CTD
PMID:22045034
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
G
Lefty1
left right determination factor 1
increases expression
ISO
cyproconazole results in increased expression of LEFTY1 mRNA
CTD
PMID:22045034
NCBI chr13:92,649,226...92,659,722
Ensembl chr13:92,656,323...92,659,720
G
Lonrf3
LON peptidase N-terminal domain and ring finger 3
decreases expression
ISO
cyproconazole results in decreased expression of LONRF3 mRNA
CTD
PMID:22334560
NCBI chr X:115,565,214...115,603,886
Ensembl chr X:115,565,267...115,598,809
G
Lrat
lecithin retinol acyltransferase
decreases expression
ISO
cyproconazole results in decreased expression of LRAT mRNA
CTD
PMID:22334560
NCBI chr 2:168,264,093...168,273,155
Ensembl chr 2:168,266,877...168,273,619
G
Lrrc3
leucine rich repeat containing 3
decreases expression
ISO
cyproconazole results in decreased expression of LRRC3 mRNA
CTD
PMID:22334560
NCBI chr20:10,758,919...10,763,736
Ensembl chr20:10,758,955...10,762,067
G
Lrrc75a
leucine rich repeat containing 75A
increases expression
EXP
cyproconazole results in increased expression of LRRC75A mRNA
CTD
PMID:22664269
NCBI chr10:47,298,222...47,343,301
Ensembl chr10:47,297,288...47,343,664
G
Lss
lanosterol synthase
multiple interactions
EXP
[cyproconazole co-treated with epoxiconazole] results in increased expression of LSS mRNA
CTD
PMID:29038839
NCBI chr20:12,091,138...12,118,858
Ensembl chr20:12,092,774...12,118,762
G
Luc7l3
LUC7-like 3 pre-mRNA splicing factor
decreases expression
ISO
cyproconazole results in decreased expression of LUC7L3 mRNA
CTD
PMID:22334560
NCBI chr10:79,240,050...79,276,555
Ensembl chr10:79,240,563...79,276,538
G
Maea
macrophage erythroblast attacher, E3 ubiquitin ligase
increases expression
ISO
cyproconazole results in increased expression of MAEA mRNA
CTD
PMID:22334560
NCBI chr14:77,357,261...77,390,683
Ensembl chr14:77,357,264...77,390,671
G
Mafb
MAF bZIP transcription factor B
decreases expression
EXP
cyproconazole results in decreased expression of MAFB mRNA
CTD
PMID:22664269
NCBI chr 3:148,998,111...149,000,031
Ensembl chr 3:148,998,122...149,000,031
G
Magt1
magnesium transporter 1
increases expression
ISO
cyproconazole results in increased expression of MAGT1 mRNA
CTD
PMID:22334560
NCBI chr X:71,038,489...71,079,704
Ensembl chr X:71,038,489...71,079,699
G
Manba
mannosidase beta
multiple interactions increases expression
EXP
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of MANBA mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of MANBA mRNA cyproconazole results in increased expression of MANBA mRNA
CTD
PMID:29038839
NCBI chr 2:223,910,432...224,002,988
Ensembl chr 2:223,910,432...224,002,983
G
Map2
microtubule-associated protein 2
increases expression
ISO
cyproconazole results in increased expression of MAP2 mRNA
CTD
PMID:22045034
NCBI chr 9:67,723,422...67,981,886
Ensembl chr 9:67,723,371...67,979,809
G
Mapk3
mitogen activated protein kinase 3
decreases expression
ISO
cyproconazole results in decreased expression of MAPK3 protein
CTD
PMID:29995386
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mbnl2
muscleblind-like splicing regulator 2
increases expression
ISO
cyproconazole results in increased expression of MBNL2 mRNA
CTD
PMID:22334560
NCBI chr15:97,385,278...97,542,924
Ensembl chr15:97,385,244...97,542,937
G
Mdm2
MDM2 proto-oncogene
multiple interactions
EXP
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of MDM2 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of MDM2 mRNA
CTD
PMID:29038839
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
G
Meig1
meiosis/spermiogenesis associated 1
increases expression
ISO
cyproconazole results in increased expression of MEIG1 mRNA
CTD
PMID:22334560
NCBI chr17:74,810,791...74,828,433
Ensembl chr17:74,814,632...74,828,433
G
Mesd
mesoderm development LRP chaperone
increases expression
ISO
cyproconazole results in increased expression of MESD mRNA
CTD
PMID:22334560
NCBI chr 1:137,866,707...137,879,999
Ensembl chr 1:137,874,242...137,879,999
G
Met
MET proto-oncogene, receptor tyrosine kinase
decreases expression
ISO
cyproconazole results in decreased expression of MET mRNA
CTD
PMID:26238599
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
G
Mfsd11
major facilitator superfamily domain containing 11
increases expression
ISO
cyproconazole results in increased expression of MFSD11 mRNA
CTD
PMID:22334560
NCBI chr10:102,055,516...102,075,064
Ensembl chr10:102,056,051...102,075,064
G
Mki67
marker of proliferation Ki-67
increases expression
ISO
cyproconazole results in increased expression of MKI67 protein
CTD
PMID:22334560
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
G
Mlec
malectin
increases expression
ISO
cyproconazole results in increased expression of MLEC mRNA
CTD
PMID:22334560
NCBI chr12:41,458,234...41,468,710
Ensembl chr12:41,458,231...41,468,708
G
Mlx
MAX dimerization protein MLX
multiple interactions
EXP
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of MLX mRNA
CTD
PMID:29038839
NCBI chr10:86,019,216...86,024,326
Ensembl chr10:86,019,588...86,032,350
G
Morc3
MORC family CW-type zinc finger 3
increases expression
ISO
cyproconazole results in increased expression of MORC3 mRNA
CTD
PMID:22334560
NCBI chr11:33,151,906...33,194,650
Ensembl chr11:33,152,025...33,194,646
G
Mrpl54
mitochondrial ribosomal protein L54
increases expression
ISO
cyproconazole results in increased expression of MRPL54 mRNA
CTD
PMID:22334560
NCBI chr 7:8,452,801...8,455,321
Ensembl chr 7:8,452,716...8,455,321
G
Mrps18b
mitochondrial ribosomal protein S18B
multiple interactions
EXP
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of MRPS18B mRNA
CTD
PMID:29038839
NCBI chr20:2,838,174...2,844,260
Ensembl chr20:2,838,030...2,844,260
G
Msmo1
methylsterol monooxygenase 1
affects expression multiple interactions
ISO EXP
cyproconazole affects the expression of MSMO1 mRNA [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of MSMO1 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of MSMO1 mRNA
CTD
PMID:22045034 PMID:29038839
NCBI chr16:24,980,680...24,997,927
Ensembl chr16:24,980,697...24,998,016
G
Msx1
msh homeobox 1
decreases expression
ISO
cyproconazole results in decreased expression of MSX1 mRNA
CTD
PMID:22045034
NCBI chr14:72,961,036...72,964,970
Ensembl chr14:72,961,148...72,964,966
G
Mt2A
metallothionein 2A
increases expression
ISO
cyproconazole results in increased expression of MT2 mRNA
CTD
PMID:22334560 PMID:23970803
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
G
Mthfr
methylenetetrahydrofolate reductase
increases expression
EXP
cyproconazole results in increased expression of MTHFR mRNA
CTD
PMID:25182419
NCBI chr 5:158,465,248...158,484,999
Ensembl chr 5:158,465,296...158,483,797
G
Mttp
microsomal triglyceride transfer protein
decreases expression
ISO
cyproconazole results in decreased expression of MTTP protein
CTD
PMID:29995386
NCBI chr 2:226,613,090...226,654,239
Ensembl chr 2:226,613,090...226,654,239
G
Mug1
murinoglobulin 1
decreases expression
ISO
cyproconazole results in decreased expression of MUG1 mRNA
CTD
PMID:22334560
NCBI chr 4:155,076,270...155,130,051
Ensembl chr 4:155,076,312...155,130,051
G
Mvd
mevalonate diphosphate decarboxylase
affects expression
ISO
cyproconazole affects the expression of MVD mRNA
CTD
PMID:22045034
NCBI chr19:50,496,366...50,506,429
Ensembl chr19:50,496,367...50,507,971
G
Mvk
mevalonate kinase
decreases expression
ISO
cyproconazole results in decreased expression of MVK mRNA
CTD
PMID:22045034
NCBI chr12:42,141,391...42,158,893
Ensembl chr12:42,141,384...42,158,882
G
Mycbp2
MYC binding protein 2
increases expression
ISO
cyproconazole results in increased expression of MYCBP2 mRNA
CTD
PMID:22045034
NCBI chr15:79,937,354...80,175,432
Ensembl chr15:79,937,354...80,175,498
G
Myo1b
myosin Ib
decreases expression
ISO
cyproconazole results in decreased expression of MYO1B mRNA
CTD
PMID:22334560
NCBI chr 9:49,690,043...49,852,373
Ensembl chr 9:49,690,086...49,850,798
G
Myo6
myosin VI
increases expression
ISO
cyproconazole results in increased expression of MYO6 mRNA
CTD
PMID:22045034
NCBI chr 8:81,087,157...81,242,022
Ensembl chr 8:81,087,139...81,239,292
G
Nagk
N-acetylglucosamine kinase
increases expression
ISO
cyproconazole results in increased expression of NAGK mRNA
CTD
PMID:22334560
NCBI chr 4:116,281,179...116,293,870
Ensembl chr 4:116,281,328...116,313,137
G
Naprt
nicotinate phosphoribosyltransferase
decreases expression
ISO
cyproconazole results in decreased expression of NAPRT mRNA
CTD
PMID:22334560
NCBI chr 7:107,576,645...107,580,102
Ensembl chr 7:107,576,627...107,580,102
G
Nat8
N-acetyltransferase 8
decreases expression
ISO
cyproconazole results in decreased expression of NAT8 mRNA
CTD
PMID:22334560
NCBI chr 4:118,279,521...118,284,671
Ensembl chr 4:118,270,954...118,281,763
G
Nat8f1
N-acetyltransferase 8 (GCN5-related) family member 1
decreases expression
ISO
cyproconazole results in decreased expression of NAT8F1 mRNA
CTD
PMID:22334560
NCBI chr 4:118,336,208...118,342,923
Ensembl chr 4:118,332,862...118,344,035
G
Nbr1
NBR1, autophagy cargo receptor
decreases expression
ISO
cyproconazole results in decreased expression of NBR1 mRNA
CTD
PMID:22334560
NCBI chr10:86,477,775...86,506,418
Ensembl chr10:86,478,290...86,506,412
G
Ndrg1
N-myc downstream regulated 1
increases expression
ISO
cyproconazole results in increased expression of NDRG1 mRNA
CTD
PMID:22334560
NCBI chr 7:98,684,487...98,725,869
Ensembl chr 7:98,684,487...98,725,880
G
Ndst1
N-deacetylase and N-sulfotransferase 1
decreases expression
ISO
cyproconazole results in decreased expression of NDST1 mRNA
CTD
PMID:22334560
NCBI chr18:54,136,887...54,199,545
Ensembl chr18:54,140,779...54,178,191
G
Nebl
nebulette
increases expression
ISO
cyproconazole results in increased expression of NEBL mRNA
CTD
PMID:22334560 PMID:23970803
NCBI chr17:80,113,891...80,466,331
Ensembl chr17:80,118,543...80,466,210
G
Nfe2l2
NFE2 like bZIP transcription factor 2
increases activity
ISO
cyproconazole results in increased activity of NFE2L2 protein
CTD
PMID:30114225
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nfib
nuclear factor I/B
decreases expression
ISO
cyproconazole results in decreased expression of NFIB mRNA
CTD
PMID:22334560
NCBI chr 5:96,759,208...96,974,001
Ensembl chr 5:96,764,653...96,975,479
G
Nploc4
NPL4 homolog, ubiquitin recognition factor
increases expression multiple interactions
EXP
cyproconazole results in increased expression of NPLOC4 mRNA [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of NPLOC4 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of NPLOC4 mRNA
CTD
PMID:29038839
NCBI chr10:105,654,395...105,709,958
Ensembl chr10:105,654,812...105,709,913
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression multiple interactions
EXP
cyproconazole results in increased expression of NQO1 mRNA [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of NQO1 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of NQO1 mRNA
CTD
PMID:25182419 PMID:29038839
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
multiple interactions increases expression
ISO
[NR1I2 protein co-treated with NR1I3 protein] affects the reaction [cyproconazole results in increased expression of ABCC3 mRNA]; [NR1I2 protein co-treated with NR1I3 protein] affects the reaction [cyproconazole results in increased expression of ABCC3 protein]; [NR1I2 protein co-treated with NR1I3 protein] affects the reaction [cyproconazole results in increased expression of AHR mRNA]; [NR1I2 protein co-treated with NR1I3 protein] affects the reaction [cyproconazole results in increased expression of CD36 mRNA]; [NR1I2 protein co-treated with NR1I3 protein] affects the reaction [cyproconazole results in increased expression of CDKN1A mRNA]; [NR1I2 protein co-treated with NR1I3 protein] affects the reaction [cyproconazole results in increased expression of CYP2B10 protein]; [NR1I3 protein co-treated with NR1I2 protein] affects the reaction [cyproconazole results in increased expression of CYP2B10 mRNA] cyproconazole results in increased expression of NR1I2 mRNA
CTD
PMID:28058446 PMID:29995386
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
multiple interactions affects response to substance increases response to substance decreases expression
ISO
NR1I3 promotes the reaction [cyproconazole results in increased expression of CYP1A2 mRNA]; NR1I3 promotes the reaction [cyproconazole results in increased expression of CYP2B10 mRNA]; NR1I3 promotes the reaction [cyproconazole results in increased expression of CYP3A11 mRNA]; NR1I3 promotes the reaction [cyproconazole results in increased expression of POR mRNA]; NR1I3 protein mutant form inhibits the reaction [cyproconazole results in increased expression of CYP2B10 mRNA]; NR1I3 protein mutant form inhibits the reaction [cyproconazole results in increased expression of CYP2B10 protein]; NR1I3 protein mutant form inhibits the reaction [cyproconazole results in increased expression of GADD45B mRNA] NR1I3 protein affects the susceptibility to cyproconazole NR1I3 results in increased susceptibility to cyproconazole cyproconazole results in decreased expression of NR1I3 mRNA [NR1I2 protein co-treated with NR1I3 protein] affects the reaction [cyproconazole results in increased expression of ABCC3 mRNA]; [NR1I2 protein co-treated with NR1I3 protein] affects the reaction [cyproconazole results in increased expression of ABCC3 protein]; [NR1I2 protein co-treated with NR1I3 protein] affects the reaction [cyproconazole results in increased expression of AHR mRNA]; [NR1I2 protein co-treated with NR1I3 protein] affects the reaction [cyproconazole results in increased expression of CD36 mRNA]; [NR1I2 protein co-treated with NR1I3 protein] affects the reaction [cyproconazole results in increased expression of CDKN1A mRNA]; [NR1I2 protein co-treated with NR1I3 protein] affects the reaction [cyproconazole results in increased expression of CYP2B10 protein]; [NR1I3 protein co-treated with NR1I2 protein] affects the reaction [cyproconazole results in increased expression of CYP2B10 mRNA]
CTD
PMID:17557908 PMID:23721867 PMID:25656644 PMID:25949234 PMID:28058446
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
G
Nrcam
neuronal cell adhesion molecule
increases expression
ISO
cyproconazole results in increased expression of NRCAM mRNA
CTD
PMID:22045034
NCBI chr 6:61,402,813...61,698,536
Ensembl chr 6:61,329,863...61,702,992
G
Nsfl1c
NSFL1 cofactor
increases expression
ISO
cyproconazole results in increased expression of NSFL1C mRNA
CTD
PMID:22334560
NCBI chr 3:139,978,306...140,002,876
Ensembl chr 3:139,978,301...140,002,870
G
Nsl1
NSL1 component of MIS12 kinetochore complex
increases expression
ISO
cyproconazole results in increased expression of NSL1 mRNA
CTD
PMID:22334560 PMID:23970803
NCBI chr13:102,649,050...102,674,059
Ensembl chr13:102,649,058...102,674,054
G
Ntrk2
neurotrophic receptor tyrosine kinase 2
increases expression
ISO
cyproconazole results in increased expression of NTRK2 mRNA
CTD
PMID:22045034
NCBI chr17:5,558,992...5,870,299
Ensembl chr17:5,559,043...5,869,136
G
Oasl
2'-5'-oligoadenylate synthetase-like
increases expression
ISO
cyproconazole results in increased expression of OASL1 mRNA
CTD
PMID:22334560
NCBI chr12:41,682,900...41,695,641
Ensembl chr12:41,682,900...41,695,641
G
Obp2a
odorant binding protein 2A
decreases expression
ISO
cyproconazole results in decreased expression of OBP2A mRNA
CTD
PMID:22334560 PMID:23970803
NCBI chr 3:8,505,963...8,509,269
Ensembl chr 3:8,505,990...8,509,269
G
Ost4
oligosaccharyltransferase complex subunit 4, non-catalytic
increases expression
ISO
cyproconazole results in increased expression of OST4 mRNA
CTD
PMID:22334560
NCBI chr 6:25,471,254...25,472,478
G
P2rx4
purinergic receptor P2X 4
increases expression
ISO
cyproconazole results in increased expression of P2RX4 mRNA
CTD
PMID:22334560
NCBI chr12:33,844,609...33,862,265
Ensembl chr12:33,844,396...33,862,253
G
Papss2
3'-phosphoadenosine 5'-phosphosulfate synthase 2
increases expression
ISO
cyproconazole results in increased expression of PAPSS2 mRNA
CTD
PMID:22334560
NCBI chr 1:230,454,314...230,539,332
Ensembl chr 1:230,454,426...230,539,331
G
Pax6
paired box 6
increases expression
ISO
cyproconazole results in increased expression of PAX6 mRNA
CTD
PMID:22045034
NCBI chr 3:92,128,772...92,157,022
Ensembl chr 3:92,135,637...92,157,014
G
Pbx1
PBX homeobox 1
increases expression
ISO
cyproconazole results in increased expression of PBX1 mRNA
CTD
PMID:22045034
NCBI chr13:80,278,766...80,588,563
Ensembl chr13:80,278,770...80,588,594
G
Pc
pyruvate carboxylase
decreases expression
ISO
cyproconazole results in decreased expression of PCX mRNA
CTD
PMID:22334560
NCBI chr 1:201,799,374...201,898,412
Ensembl chr 1:201,804,267...201,898,380
G
Pcmtd1
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1
decreases expression
ISO
cyproconazole results in decreased expression of PCMTD1 mRNA
CTD
PMID:22334560
NCBI chr 5:12,284,711...12,355,680
Ensembl chr 5:12,284,711...12,354,899
G
Pde11a
phosphodiesterase 11A
decreases expression
EXP
cyproconazole results in decreased expression of PDE11A mRNA
CTD
PMID:22664269
NCBI chr 3:60,913,562...61,297,154
Ensembl chr 3:60,913,562...61,297,158
G
Pepd
peptidase D
increases expression
ISO
cyproconazole results in increased expression of PEPD mRNA
CTD
PMID:22334560
NCBI chr 1:87,536,650...87,681,233
Ensembl chr 1:87,536,609...87,681,231
G
Pipox
pipecolic acid and sarcosine oxidase
decreases expression
ISO
cyproconazole results in decreased expression of PIPOX mRNA
CTD
PMID:22334560
NCBI chr10:62,769,874...62,783,484
Ensembl chr10:62,769,900...62,782,370
G
Pla2g12a
phospholipase A2, group XIIA
increases expression
ISO
cyproconazole results in increased expression of PLA2G12A mRNA
CTD
PMID:22334560
NCBI chr 2:218,436,497...218,452,742
Ensembl chr 2:218,436,513...218,452,740
G
Pla2g6
phospholipase A2 group VI
increases expression
ISO
cyproconazole results in increased expression of PLA2G6 mRNA
CTD
PMID:22334560
NCBI chr 7:110,851,378...110,891,557
Ensembl chr 7:110,851,378...110,891,114
G
Plbd1
phospholipase B domain containing 1
increases expression
ISO
cyproconazole results in increased expression of PLBD1 mRNA
CTD
PMID:22334560
NCBI chr 4:169,472,983...169,529,277
Ensembl chr 4:169,472,983...169,529,277
G
Plin5
perilipin 5
decreases expression
ISO
cyproconazole results in decreased expression of PLIN5 mRNA
CTD
PMID:22334560
NCBI chr 9:939,745...946,188
Ensembl chr 9:939,747...946,120
G
Pmvk
phosphomevalonate kinase
decreases expression
ISO
cyproconazole results in decreased expression of PMVK mRNA
CTD
PMID:22045034
NCBI chr 2:174,876,586...174,886,365
Ensembl chr 2:174,876,657...174,886,364
G
Pnpla7
patatin-like phospholipase domain containing 7
decreases expression
ISO
cyproconazole results in decreased expression of PNPLA7 mRNA
CTD
PMID:22334560
NCBI chr 3:7,782,572...7,861,504
Ensembl chr 3:7,782,572...7,861,497
G
Pon3
paraoxonase 3
increases expression
ISO
cyproconazole results in increased expression of PON3 mRNA
CTD
PMID:22334560
NCBI chr 4:33,356,983...33,383,681
Ensembl chr 4:33,349,168...33,383,855
G
Por
cytochrome p450 oxidoreductase
increases expression multiple interactions
ISO EXP
cyproconazole results in increased expression of POR mRNA NR1I3 promotes the reaction [cyproconazole results in increased expression of POR mRNA] [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of POR mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of POR mRNA
CTD
PMID:22334560 PMID:23970803 PMID:25656644 PMID:29038839
NCBI chr12:20,951,058...20,999,198
Ensembl chr12:20,951,058...20,999,245
G
Ppara
peroxisome proliferator activated receptor alpha
decreases expression
ISO
cyproconazole results in decreased expression of PPARA mRNA
CTD
PMID:22334560
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
G
Ppargc1a
PPARG coactivator 1 alpha
increases expression multiple interactions
EXP
cyproconazole results in increased expression of PPARGC1A mRNA [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of PPARGC1A mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of PPARGC1A mRNA
CTD
PMID:29038839
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
G
Ppm1k
protein phosphatase, Mg2+/Mn2+ dependent, 1K
decreases expression
ISO
cyproconazole results in decreased expression of PPM1K mRNA
CTD
PMID:22334560
NCBI chr 4:87,612,198...87,638,993
Ensembl chr 4:87,612,204...87,636,152
G
Ppp1cc
protein phosphatase 1 catalytic subunit gamma
increases expression
ISO
cyproconazole results in increased expression of PPP1CC mRNA
CTD
PMID:22334560
NCBI chr12:34,383,072...34,400,553
Ensembl chr12:34,383,072...34,400,553
G
Ppp1r42
protein phosphatase 1, regulatory subunit 42
increases expression
ISO
cyproconazole results in increased expression of PPP1R42 mRNA
CTD
PMID:22334560
NCBI chr 5:9,227,109...9,274,461
Ensembl chr 5:9,227,204...9,274,453
G
Prg4
proteoglycan 4
increases expression
ISO
cyproconazole results in increased expression of PRG4 mRNA
CTD
PMID:22334560
NCBI chr13:62,487,257...62,504,657
Ensembl chr13:62,487,257...62,504,119
G
Prkaa2
protein kinase AMP-activated catalytic subunit alpha 2
increases expression
ISO
cyproconazole results in increased expression of PRKAA2 mRNA
CTD
PMID:22045034
NCBI chr 5:119,807,992...119,879,987
Ensembl chr 5:119,813,226...119,879,543
G
Prlr
prolactin receptor
decreases expression
ISO
cyproconazole results in decreased expression of PRLR mRNA
CTD
PMID:22334560
NCBI chr 2:59,134,147...59,324,719
Ensembl chr 2:59,134,588...59,324,718
G
Prpf19
pre-mRNA processing factor 19
increases expression
ISO
cyproconazole results in increased expression of PRPF19 mRNA
CTD
PMID:22334560
NCBI chr 1:207,541,582...207,552,664
Ensembl chr 1:207,541,595...207,552,662
G
Psap
prosaposin
increases expression
ISO
cyproconazole results in increased expression of PSAP mRNA
CTD
PMID:22334560
NCBI chr20:28,214,229...28,240,501
Ensembl chr20:28,214,271...28,240,498
G
Psen1
presenilin 1
increases expression
ISO
cyproconazole results in increased expression of PSEN1 mRNA
CTD
PMID:22334560
NCBI chr 6:103,323,052...103,375,088
Ensembl chr 6:103,323,120...103,371,650
G
Psma5
proteasome 20S subunit alpha 5
increases expression
ISO
cyproconazole results in increased expression of PSMA5 mRNA
CTD
PMID:22334560
NCBI chr 2:195,896,369...195,919,733
Ensembl chr 2:195,896,365...195,919,731
G
Psmd12
proteasome 26S subunit, non-ATPase 12
increases expression
ISO
cyproconazole results in increased expression of PSMD12 mRNA
CTD
PMID:22334560
NCBI chr10:92,438,223...92,457,323
Ensembl chr10:92,438,298...92,457,287
G
Pvr
PVR cell adhesion molecule
increases expression
EXP
cyproconazole results in increased expression of PVR mRNA
CTD
PMID:29038839
NCBI chr 1:79,561,294...79,576,700
Ensembl chr 1:79,546,879...79,576,715
G
Rab3gap1
RAB3 GTPase activating protein catalytic subunit 1
decreases expression
ISO
cyproconazole results in decreased expression of RAB3GAP1 mRNA
CTD
PMID:22334560
NCBI chr13:39,355,698...39,429,154
Ensembl chr13:39,352,247...39,429,169
G
Rac2
Rac family small GTPase 2
increases expression
ISO
cyproconazole results in increased expression of RAC2 mRNA
CTD
PMID:26238599
NCBI chr 7:110,101,344...110,128,718
Ensembl chr 7:110,116,260...110,128,720
G
Rapgef4
Rap guanine nucleotide exchange factor 4
increases expression
ISO
cyproconazole results in increased expression of RAPGEF4 mRNA
CTD
PMID:22334560
NCBI chr 3:56,809,388...57,101,332
Ensembl chr 3:56,809,270...57,102,316
G
Rarb
retinoic acid receptor, beta
increases expression
ISO
cyproconazole results in increased expression of RARB mRNA
CTD
PMID:22045034
NCBI chr15:8,700,533...9,051,288
Ensembl chr15:8,406,492...9,051,288
G
Rbbp8
RB binding protein 8, endonuclease
increases expression
ISO
cyproconazole results in increased expression of RBBP8 mRNA
CTD
PMID:22334560
NCBI chr18:2,922,985...2,988,851
Ensembl chr18:2,921,286...2,988,846
G
Rcn2
reticulocalbin 2
increases expression
ISO
cyproconazole results in increased expression of RCN2 mRNA
CTD
PMID:22334560
NCBI chr 8:56,449,206...56,466,253
Ensembl chr 8:56,449,206...56,466,251
G
Rflna
refilin A
increases expression
EXP
cyproconazole results in increased expression of RFLNA mRNA
CTD
PMID:22664269
NCBI chr12:31,633,360...31,642,313
Ensembl chr12:31,633,361...31,642,317
G
Rgn
regucalcin
decreases expression
ISO
cyproconazole results in decreased expression of RGN mRNA
CTD
PMID:22334560
NCBI chr X:1,619,030...1,634,456
Ensembl chr X:1,619,032...1,634,450
G
Rhbdd1
rhomboid domain containing 1
increases expression
ISO
cyproconazole results in increased expression of RHBDD1 mRNA
CTD
PMID:22334560
NCBI chr 9:83,630,037...83,748,690
Ensembl chr 9:83,630,063...83,748,689
G
Rhoc
ras homolog family member C
decreases expression
ISO
cyproconazole results in decreased expression of RHOC mRNA
CTD
PMID:26238599
NCBI chr 2:192,287,065...192,293,292
Ensembl chr 2:192,287,130...192,295,306
G
Rnd3
Rho family GTPase 3
decreases expression
ISO
cyproconazole results in decreased expression of RND3 mRNA
CTD
PMID:26238599
NCBI chr 3:35,571,929...35,589,283
Ensembl chr 3:35,571,143...35,589,327
G
Rras
RAS related
increases expression
ISO
cyproconazole results in increased expression of RRAS mRNA
CTD
PMID:22334560
NCBI chr 1:95,500,582...95,504,362
Ensembl chr 1:95,500,566...95,504,357
G
Rsad2
radical S-adenosyl methionine domain containing 2
increases expression
ISO
cyproconazole results in increased expression of RSAD2 mRNA
CTD
PMID:22334560
NCBI chr 6:43,046,514...43,059,737
Ensembl chr 6:43,047,658...43,059,699
G
S100a8
S100 calcium binding protein A8
increases expression
ISO
cyproconazole results in increased expression of S100A8 mRNA
CTD
PMID:22334560
NCBI chr 2:176,166,517...176,167,645
Ensembl chr 2:176,167,124...176,167,643
G
Sar1b
secretion associated, Ras related GTPase 1B
increases expression
ISO
cyproconazole results in increased expression of SAR1B mRNA
CTD
PMID:22334560
NCBI chr10:36,024,415...36,054,069
Ensembl chr10:36,024,382...36,054,066
G
Scap
SREBF chaperone
decreases expression
ISO
cyproconazole results in decreased expression of SCAP mRNA
CTD
PMID:22334560
NCBI chr 8:110,306,026...110,360,677
Ensembl chr 8:110,306,031...110,360,666
G
Scarb1
scavenger receptor class B, member 1
increases expression
ISO
cyproconazole results in increased expression of SCARB1 mRNA
CTD
PMID:22045034
NCBI chr12:31,296,143...31,362,649
Ensembl chr12:31,296,156...31,362,647
G
Scd
stearoyl-CoA desaturase
increases expression
ISO
cyproconazole results in increased expression of SCD mRNA
CTD
PMID:29995386
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
G
Sec22b
SEC22 homolog B, vesicle trafficking protein
increases expression
ISO
cyproconazole results in increased expression of SEC22B mRNA
CTD
PMID:22334560
NCBI chr 2:185,500,029...185,520,811
Ensembl chr 2:185,500,004...185,522,026
G
Sec24d
SEC24 homolog D, COPII coat complex component
increases expression
ISO
cyproconazole results in increased expression of SEC24D mRNA
CTD
PMID:22334560
NCBI chr 2:211,418,557...211,526,588
Ensembl chr 2:211,418,623...211,526,587
G
Sec61a1
SEC61 translocon subunit alpha 1
increases expression
ISO
cyproconazole results in increased expression of SEC61A1 mRNA
CTD
PMID:22334560
NCBI chr 4:120,973,519...120,987,871
Ensembl chr 4:120,960,626...120,987,925
G
Sec61b
SEC61 translocon subunit beta
increases expression
ISO
cyproconazole results in increased expression of SEC61B mRNA
CTD
PMID:22334560
NCBI chr 5:61,773,594...61,781,804
Ensembl chr 5:61,773,594...61,781,804
G
Selenos
selenoprotein S
increases expression
ISO
cyproconazole results in increased expression of SELENOS mRNA
CTD
PMID:22334560
NCBI chr 1:119,659,779...119,669,546
Ensembl chr 1:119,659,751...119,669,833
G
Serpina6
serpin family A member 6
increases expression
ISO
cyproconazole results in increased expression of SERPINA6 mRNA
CTD
PMID:22334560
NCBI chr 6:122,780,040...122,790,274
Ensembl chr 6:122,780,043...122,790,349
G
Serpina9
serpin family A member 9
decreases expression
ISO
cyproconazole results in decreased expression of SERPINA9 mRNA
CTD
PMID:22334560
NCBI chr 6:122,918,819...122,936,000
Ensembl chr 6:122,918,880...122,936,000
G
Serpinf1
serpin family F member 1
increases expression
EXP
cyproconazole results in increased expression of SERPINF1 mRNA
CTD
PMID:22664269
NCBI chr10:60,250,198...60,262,593
Ensembl chr10:60,249,708...60,262,646
G
Sf3b2
splicing factor 3b, subunit 2
decreases expression
ISO
cyproconazole results in decreased expression of SF3B2 mRNA
CTD
PMID:22334560
NCBI chr 1:202,570,423...202,590,774
Ensembl chr 1:202,570,423...202,590,759
G
Sgpl1
sphingosine-1-phosphate lyase 1
increases expression
ISO
cyproconazole results in increased expression of SGPL1 mRNA
CTD
PMID:22334560
NCBI chr20:29,047,793...29,094,209
Ensembl chr20:29,047,796...29,094,084
G
Siae
sialic acid acetylesterase
increases expression
ISO
cyproconazole results in increased expression of SIAE mRNA
CTD
PMID:22334560
NCBI chr 8:37,318,724...37,354,004
Ensembl chr 8:37,318,747...37,353,996
G
Sirpa
signal-regulatory protein alpha
increases expression
ISO
cyproconazole results in increased expression of SIRPA mRNA
CTD
PMID:22334560
NCBI chr 3:116,819,730...116,858,099
Ensembl chr 3:116,819,726...116,858,098
G
Slc10a1
solute carrier family 10 member 1
increases expression decreases expression
ISO
cyproconazole results in increased expression of SLC10A1 mRNA cyproconazole results in decreased expression of SLC10A1 protein
CTD
PMID:22334560 PMID:33150952
NCBI chr 6:100,613,045...100,626,670
Ensembl chr 6:100,613,045...100,626,670
G
Slc13a3
solute carrier family 13 member 3
increases expression
ISO
cyproconazole results in increased expression of SLC13A3 mRNA
CTD
PMID:22334560
NCBI chr 3:154,141,878...154,204,604
Ensembl chr 3:154,141,872...154,204,606
G
Slc16a12
solute carrier family 16, member 12
increases expression
ISO
cyproconazole results in increased expression of SLC16A12 mRNA
CTD
PMID:22334560
NCBI chr 1:232,184,004...232,262,170
Ensembl chr 1:232,185,907...232,262,141
G
Slc23a1
solute carrier family 23 member 1
increases expression
ISO
cyproconazole results in increased expression of SLC23A1 mRNA
CTD
PMID:22334560
NCBI chr18:27,214,940...27,230,564
Ensembl chr18:27,216,281...27,230,697
G
Slc23a2
solute carrier family 23 member 2
increases expression
ISO
cyproconazole results in increased expression of SLC23A2 mRNA
CTD
PMID:22334560
NCBI chr 3:119,302,651...119,395,289
Ensembl chr 3:119,302,666...119,460,343
G
Slc25a15
solute carrier family 25 member 15
decreases expression
ISO
cyproconazole results in decreased expression of SLC25A15 mRNA
CTD
PMID:22334560
NCBI chr16:69,631,581...69,654,869
Ensembl chr16:69,634,414...69,653,010
G
Slc25a22
solute carrier family 25 member 22
decreases expression
ISO
cyproconazole results in decreased expression of SLC25A22 mRNA
CTD
PMID:22334560
NCBI chr 1:196,528,471...196,536,398
Ensembl chr 1:196,528,472...196,536,331
G
Slc25a37
solute carrier family 25 member 37
increases expression
ISO
cyproconazole results in increased expression of SLC25A37 mRNA
CTD
PMID:22334560
NCBI chr15:44,534,280...44,576,697
Ensembl chr15:44,536,727...44,577,199
G
Slc39a11
solute carrier family 39, member 11
increases expression
ISO
cyproconazole results in increased expression of SLC39A11 mRNA
CTD
PMID:22334560
NCBI chr10:98,275,958...98,697,042
Ensembl chr10:98,275,960...98,611,295
G
Slc48a1
solute carrier family 48 member 1
increases expression
ISO
cyproconazole results in increased expression of SLC48A1 mRNA
CTD
PMID:22334560
NCBI chr 7:128,915,136...128,923,929
Ensembl chr 7:128,915,195...128,923,024
G
Slco1a4
solute carrier organic anion transporter family, member 1a4
increases expression
ISO
cyproconazole results in increased expression of SLCO1A4 mRNA
CTD
PMID:22334560 PMID:23970803
NCBI chr 4:174,710,004...174,764,810
Ensembl chr 4:174,710,004...175,254,573
G
Slit2
slit guidance ligand 2
increases expression
ISO
cyproconazole results in increased expression of SLIT2 mRNA
CTD
PMID:22045034
NCBI chr14:62,616,337...62,955,934
Ensembl chr14:62,617,067...62,955,948
G
Smarca4
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
decreases expression
ISO
cyproconazole results in decreased expression of SMARCA4 mRNA
CTD
PMID:22334560
NCBI chr 8:20,167,717...20,258,975
Ensembl chr 8:20,167,717...20,258,975
G
Smpd3
sphingomyelin phosphodiesterase 3
increases expression
ISO
cyproconazole results in increased expression of SMPD3 mRNA
CTD
PMID:22334560
NCBI chr19:34,162,337...34,245,786
Ensembl chr19:34,162,341...34,245,749
G
Snx17
sorting nexin 17
decreases expression
ISO
cyproconazole results in decreased expression of SNX17 mRNA
CTD
PMID:22334560
NCBI chr 6:25,177,528...25,183,001
Ensembl chr 6:25,177,391...25,183,030
G
Socs3
suppressor of cytokine signaling 3
affects expression
ISO
cyproconazole affects the expression of SOCS3 mRNA
CTD
PMID:22045034
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
G
Spcs2
signal peptidase complex subunit 2
increases expression
ISO
cyproconazole results in increased expression of SPCS2 mRNA
CTD
PMID:22334560
NCBI chr 1:154,163,724...154,183,152
Ensembl chr 1:154,163,724...154,183,186
G
Spry2
sprouty RTK signaling antagonist 2
decreases expression
ISO
cyproconazole results in decreased expression of SPRY2 mRNA
CTD
PMID:22045034
NCBI chr15:82,692,291...82,697,408
Ensembl chr15:82,692,143...82,698,009
G
Srd5a1
steroid 5 alpha-reductase 1
increases expression
ISO
cyproconazole results in increased expression of SRD5A1 mRNA
CTD
PMID:22334560
NCBI chr 1:33,686,069...33,720,468
Ensembl chr 1:33,686,391...33,720,461
G
Srpra
SRP receptor subunit alpha
increases expression
ISO
cyproconazole results in increased expression of SRPRA mRNA
CTD
PMID:22334560
NCBI chr 8:33,560,365...33,566,458
Ensembl chr 8:33,560,348...33,566,470
G
Srxn1
sulfiredoxin 1
increases expression
ISO
cyproconazole results in increased expression of SRXN1 mRNA
CTD
PMID:22334560
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
G
Star
steroidogenic acute regulatory protein
multiple interactions
EXP
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of STAR mRNA
CTD
PMID:28454766
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
G
Stat5b
signal transducer and activator of transcription 5B
decreases activity
ISO
cyproconazole results in decreased activity of STAT5B protein
CTD
PMID:30114225
NCBI chr10:85,704,841...85,775,856
Ensembl chr10:85,705,670...85,775,668
G
Stbd1
starch binding domain 1
increases expression
ISO EXP
cyproconazole results in increased expression of STBD1 mRNA
CTD
PMID:22334560 PMID:29038839
NCBI chr14:15,470,452...15,473,857
Ensembl chr14:15,469,582...15,477,443
G
Stt3a
STT3 oligosaccharyltransferase complex catalytic subunit A
increases expression
ISO
cyproconazole results in increased expression of STT3A mRNA
CTD
PMID:22334560
NCBI chr 8:36,443,623...36,483,111
Ensembl chr 8:36,446,788...36,483,293
G
Sult1b1
sulfotransferase family 1B member 1
decreases expression
ISO
cyproconazole results in decreased expression of SULT1B1 mRNA
CTD
PMID:29995386
NCBI chr14:20,492,763...20,505,491
Ensembl chr14:20,492,708...20,505,483
G
Tbx3
T-box transcription factor 3
decreases expression
ISO
cyproconazole results in decreased expression of TBX3 mRNA
CTD
PMID:22045034
NCBI chr12:36,879,924...36,894,849
Ensembl chr12:36,881,445...36,893,708
G
Tgfa
transforming growth factor alpha
increases expression
ISO
cyproconazole results in increased expression of TGFA mRNA
CTD
PMID:22334560
NCBI chr 4:118,618,043...118,700,897
Ensembl chr 4:118,618,269...118,700,894
G
Tgfbr2
transforming growth factor, beta receptor 2
increases expression
ISO
cyproconazole results in increased expression of TGFBR2 mRNA
CTD
PMID:22334560
NCBI chr 8:115,794,537...115,883,615
Ensembl chr 8:115,794,537...115,883,228
G
Thoc2
THO complex subunit 2
decreases expression
ISO
cyproconazole results in decreased expression of THOC2 mRNA
CTD
PMID:22334560
NCBI chr X:120,634,966...120,749,569
Ensembl chr X:120,634,968...120,749,513
G
Timm10b
translocase of inner mitochondrial membrane 10B
multiple interactions
EXP
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of TIMM10B mRNA
CTD
PMID:29038839
NCBI chr 1:159,980,525...159,983,371
Ensembl chr 1:159,980,484...159,981,642
G
Tlr2
toll-like receptor 2
increases expression
ISO
cyproconazole results in increased expression of TLR2 mRNA
CTD
PMID:22334560
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tm7sf2
transmembrane 7 superfamily member 2
affects expression
ISO
cyproconazole affects the expression of TM7SF2 mRNA
CTD
PMID:22045034
NCBI chr 1:203,355,930...203,360,287
Ensembl chr 1:203,355,931...203,360,270
G
Tm9sf4
transmembrane 9 superfamily member 4
increases expression
ISO
cyproconazole results in increased expression of TM9SF4 mRNA
CTD
PMID:22334560
NCBI chr 3:141,627,128...141,675,386
Ensembl chr 3:141,627,346...141,675,386
G
Tmbim4
transmembrane BAX inhibitor motif containing 4
increases expression
ISO
cyproconazole results in increased expression of TMBIM4 mRNA
CTD
PMID:22334560
NCBI chr 7:55,718,690...55,733,277
Ensembl chr 7:55,718,699...55,742,773
G
Tmed10
transmembrane p24 trafficking protein 10
increases expression
ISO
cyproconazole results in increased expression of TMED10 mRNA
CTD
PMID:22334560
NCBI chr 6:104,991,843...105,026,705
Ensembl chr 6:104,991,838...105,026,753
G
Tmed3
transmembrane p24 trafficking protein 3
increases expression
ISO
cyproconazole results in increased expression of TMED3 mRNA
CTD
PMID:22334560
NCBI chr 8:90,241,516...90,249,429
Ensembl chr 8:90,241,516...90,249,346
G
Tmem109
transmembrane protein 109
increases expression
ISO
cyproconazole results in increased expression of TMEM109 mRNA
CTD
PMID:22334560
NCBI chr 1:207,519,628...207,530,245
Ensembl chr 1:207,519,624...207,530,215
G
Tmem167a
transmembrane protein 167A
increases expression
ISO
cyproconazole results in increased expression of TMEM167 mRNA
CTD
PMID:22334560
NCBI chr 2:21,197,799...21,216,746
Ensembl chr 2:21,197,786...21,212,099
G
Tmem176a
transmembrane protein 176A
increases expression
ISO
cyproconazole results in increased expression of TMEM176A mRNA
CTD
PMID:22334560
NCBI chr 4:77,774,940...77,778,620
Ensembl chr 4:77,774,843...77,778,620
G
Tmem176b
transmembrane protein 176B
increases expression
ISO
cyproconazole results in increased expression of TMEM176B mRNA
CTD
PMID:22334560
NCBI chr 4:77,766,928...77,774,740
Ensembl chr 4:77,766,928...77,774,384
G
Tmem43
transmembrane protein 43
increases expression
ISO
cyproconazole results in increased expression of TMEM43 mRNA
CTD
PMID:22334560
NCBI chr 4:123,977,680...123,992,823
Ensembl chr 4:123,977,625...123,992,825
G
Tmt1a
thiol methyltransferase 1A
increases expression
ISO
cyproconazole results in increased expression of TMT1A mRNA
CTD
PMID:22334560
NCBI chr 7:131,452,099...131,460,154
Ensembl chr 7:131,451,641...131,460,154
G
Tmx2
thioredoxin-related transmembrane protein 2
increases expression
ISO
cyproconazole results in increased expression of TMX2 mRNA
CTD
PMID:22334560
NCBI chr 3:69,754,937...69,762,587
Ensembl chr 3:69,754,939...69,762,587
G
Tnfrsf19
TNF receptor superfamily member 19
increases expression
ISO
cyproconazole results in increased expression of TNFRSF19 mRNA
CTD
PMID:22334560 PMID:23970803
NCBI chr15:35,092,206...35,158,472
Ensembl chr15:35,092,206...35,180,795
G
Tnks2
tankyrase 2
decreases expression
ISO
cyproconazole results in decreased expression of TNKS2 mRNA
CTD
PMID:22334560
NCBI chr 1:234,567,888...234,621,079
Ensembl chr 1:234,567,858...234,621,079
G
Tor1b
torsin family 1, member B
increases expression
ISO
cyproconazole results in increased expression of TOR1B mRNA
CTD
PMID:22334560
NCBI chr 3:14,243,181...14,249,279
Ensembl chr 3:14,243,243...14,249,272
G
Tshz1
teashirt zinc finger homeobox 1
increases expression
ISO
cyproconazole results in increased expression of TSHZ1 mRNA
CTD
PMID:22045034
NCBI chr18:77,376,399...77,452,815
Ensembl chr18:77,377,394...77,453,509
G
Ttc39c
tetratricopeptide repeat domain 39C
decreases expression
ISO
cyproconazole results in decreased expression of TTC39C mRNA
CTD
PMID:22334560
NCBI chr18:3,768,802...3,887,932
Ensembl chr18:3,805,183...3,887,930
G
Txn1
thioredoxin 1
increases expression
ISO
cyproconazole results in increased expression of TXN1 mRNA
CTD
PMID:22334560
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
G
Txndc17
thioredoxin domain containing 17
increases expression
ISO
cyproconazole results in increased expression of TXNDC17 mRNA
CTD
PMID:22334560
NCBI chr10:56,832,749...56,835,721
G
Uba5
ubiquitin-like modifier activating enzyme 5
increases expression
ISO
cyproconazole results in increased expression of UBA5 mRNA
CTD
PMID:22334560
NCBI chr 8:104,665,241...104,680,915
Ensembl chr 8:104,665,046...104,680,894
G
Ubb
ubiquitin B
increases expression
ISO
cyproconazole results in increased expression of UBB mRNA
CTD
PMID:22334560
NCBI chr10:47,247,630...47,249,335
Ensembl chr10:47,245,637...47,249,333
G
Ubn1
ubinuclein 1
decreases expression
ISO
cyproconazole results in decreased expression of UBN1 mRNA
CTD
PMID:22334560
NCBI chr10:10,496,576...10,532,010
Ensembl chr10:10,496,576...10,532,010
G
Ubqln2
ubiquilin 2
multiple interactions increases expression
EXP
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of UBQLN2 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of UBQLN2 mRNA cyproconazole results in increased expression of UBQLN2 mRNA
CTD
PMID:29038839
NCBI chr X:17,853,086...17,856,505
Ensembl chr X:17,853,114...17,856,505
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
increases expression multiple interactions
EXP
cyproconazole results in increased expression of UGT1A1 mRNA [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of UGT1A1 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of UGT1A1 mRNA
CTD
PMID:29038839
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a9
UDP glucuronosyltransferase family 1 member A9
increases expression
ISO
cyproconazole results in increased expression of UGT1A9 mRNA
CTD
PMID:22334560
NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt2b1
UDP glucuronosyltransferase 2 family, polypeptide B1
increases expression multiple interactions
EXP
cyproconazole results in increased expression of UGT2B1 mRNA [cyproconazole co-treated with epoxiconazole] results in increased expression of UGT2B1 mRNA
CTD
PMID:29038839
NCBI chr14:21,024,035...21,035,784
Ensembl chr14:21,024,006...21,035,986
G
Ugt2b7
UDP glucuronosyltransferase family 2 member B7
decreases expression increases expression
ISO
cyproconazole results in decreased expression of UGT2B7 protein cyproconazole results in increased expression of UGT2B34 mRNA
CTD
PMID:22334560 PMID:29995386
NCBI chr14:20,896,682...20,919,604
Ensembl chr14:20,896,682...20,919,604
G
Ulk2
unc-51 like autophagy activating kinase 2
increases expression
ISO
cyproconazole results in increased expression of ULK2 mRNA
CTD
PMID:22045034
NCBI chr10:46,451,578...46,530,462
Ensembl chr10:46,454,030...46,530,407
G
Vasp
vasodilator-stimulated phosphoprotein
decreases expression
ISO
cyproconazole results in decreased expression of VASP mRNA
CTD
PMID:22045034
NCBI chr 1:78,910,009...78,925,791
Ensembl chr 1:78,910,011...78,925,061
G
Vps29
VPS29 retromer complex component
increases expression
ISO
cyproconazole results in increased expression of VPS29 mRNA
CTD
PMID:22334560
NCBI chr12:34,208,911...34,217,977
Ensembl chr12:34,207,263...34,217,964
G
Vti1b
vesicle transport through interaction with t-SNAREs 1B
increases expression
ISO
cyproconazole results in increased expression of VTI1B mRNA
CTD
PMID:22334560
NCBI chr 6:97,957,700...97,976,491
Ensembl chr 6:97,961,346...97,976,465
G
Vtn
vitronectin
decreases expression
ISO
cyproconazole results in decreased expression of VTN mRNA
CTD
PMID:22334560
NCBI chr10:63,394,732...63,397,812
Ensembl chr10:63,394,719...63,397,810
G
Wdr18
WD repeat domain 18
increases expression
ISO
cyproconazole results in increased expression of WDR18 mRNA
CTD
PMID:22334560
NCBI chr 7:9,740,245...9,748,041
Ensembl chr 7:9,739,604...9,748,070
G
Xiap
X-linked inhibitor of apoptosis
decreases expression
ISO
cyproconazole results in decreased expression of XIAP mRNA
CTD
PMID:22334560
NCBI chr X:120,890,537...120,938,413
Ensembl chr X:120,897,907...120,934,700
G
Xrcc1
X-ray repair cross complementing 1
increases expression multiple interactions
EXP
cyproconazole results in increased expression of XRCC1 mRNA [cyproconazole co-treated with epoxiconazole] results in increased expression of XRCC1 mRNA
CTD
PMID:29038839
NCBI chr 1:80,140,495...80,168,705
Ensembl chr 1:80,141,207...80,168,701
G
Xrcc5
X-ray repair cross complementing 5
multiple interactions
EXP
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of XRCC5 mRNA
CTD
PMID:29038839
NCBI chr 9:73,955,216...74,044,020
Ensembl chr 9:73,955,216...74,044,018
G
Yipf5
Yip1 domain family, member 5
increases expression
ISO
cyproconazole results in increased expression of YIPF5 mRNA
CTD
PMID:22334560
NCBI chr18:32,123,814...32,136,947
Ensembl chr18:32,123,842...32,157,642
G
Zbtb16
zinc finger and BTB domain containing 16
increases expression
ISO
cyproconazole results in increased expression of ZBTB16 mRNA
CTD
PMID:22045034
NCBI chr 8:48,989,376...49,177,011
Ensembl chr 8:48,994,566...49,177,011
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all